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Abstract 
Histidine-to-aspartate multi-step phosphorelay systems are used extensively by 
eukaryotes and bacteria to sense and respond to changes in their external environment 
and to control the regulation of crucial biological functions such as cell cycle, mating, 
and virulence. These pathways generally consists of a hybrid histidine kinase (HHK), a 
single histidine phosphotransfer protein (HPt), and one or more response regulator 
proteins (RR). The histidine phosphotransfer protein, Ypd1, is found at the branch point 
of these signal transduction pathways in several fungal organisms, and acts as an 
intermediate that is responsible for relaying messages between the HHK, which senses 
the signal, and the RR, which initiates a cellular response. This protein, or a homolog, is 
often the sole HPt in fungal organisms. In several fungal species it has been shown to be 
essential for viability. These organisms include the common baker’s yeast 
Saccharomyces cerevisiae (Sc) and the human fungal pathogen Cryptococcus 
neoformans (Cn). 
HPt proteins are genetically diverse, but share a common tertiary fold with 
conserved residues near the active site.  A surface-exposed glycine at the H+4 position, 
relative to the phosphorylatable histidine is found in a significant number of annotated 
HPts.  Substitution of residues with larger side chains at this position typically disrupts 
signal transduction by altering the structure and/or enzymatic activity of the 
phosphotransfer-competent complex formed between HPts and their cognate partners.  
 Previous work using yeast two-hybrid assays has shown that the residue in the 
H+4 position on the surface of ScYpd1 in the G68 position has an only slightly 
diminished activity in its ability to accept a phosphoryl group from the receiver domain 
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of ScSln1, but a highly diminished activity in its ability to transfer its phosphoryl group 
to the receiver domain of ScSsk1.  Here we report a comprehensive analysis of a set of 
point mutants at position 68 of Ypd1 to gain insights into the evolutionary constraints 
leading to the exceptionally high conservation of glycine at position H+4 in HPts. We 
combine bioinformatics, phosphoryl transfer assays, X-ray crystallography, 
fluorescence-based binding assay and molecular dynamics techniques to help explain 
the delicate balance of interatomic interactions required for phosphotransfer to occur 
between an HPt and its cognate RR. The conclusions that can be drawn clarify the 
importance of a small and/or hydrophilic residue in the H+4 position. 
Ypd1 from C. neoformans is distinct from Ypd1 from S. cerevisiae. Based on 
sequence alignments, CnYpd1 includes an extended N-terminal region that is not 
present in ScYpd1 of approximately 60 residues. This extended N-terminal region 
shares no close sequence homology with any other known protein domain.  Organisms 
with stand-alone HPt proteins that include an extended N-terminal region are rare, and 
are found strictly in fungal species that have been shown to be pathogenic to plants or 
humans, or that live in extreme environments.   Results from this study indicate that 
CnYpd1 exhibits unique characteristics in comparison to other histidine 
phosphotransfer proteins, such as an extended N-terminal amino acid sequence, which 
we find contributes to structural integrity, a longer phosphorylated life-time and the 
ability to bind calcium ions.  
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Introduction 
1.1 Signal transduction through histidine-to-aspartate pathways 
Sensing external environment and responding to changes detected is crucial to 
an organism’s ability to survive and proliferate. Stimuli are sensed through a multitude 
of mechanisms, such as small molecule/hormone binding, or through structural changes 
of cellular components such as proteins. Frequently, the response to an external 
stimulus is an alteration in gene expression. This process of transmitting external 
stimuli to the interior of the cell is known as signal transduction. One of the most 
common signal transduction mechanisms is the reversible transfer of a phosphoryl 
group between proteins in signaling pathways [1, 2].  
 The most common form of phosphoryl group transfer involves the 
phosphorylation and dephosphorylation of serine, threonine, and tyrosine residues [3, 
4]. However, in bacteria this type of phosphorylation is less common, and histidine-to-
aspartate (His-to-Asp) phosphotransfer pathways dominate signal transduction 
mechanisms [5]. These pathways are called “two-component systems.”  According to 
the Prokaryotic 2-Component Systems (P2CS) Database (http://www.p2cs.org/), a 
comprehensive database of two-component systems from organisms with completely 
sequenced genomes, on average more than 50 two-component system proteins are 
encoded by a bacterial species, which accounts for as much as 1% of all the encoded 
proteins [6, 7]. Two-component systems are used in stress response and the regulation 
of other essential or beneficial biological functions such as cell proliferation, virulence, 
and antibiotic resistance [5, 8].  
In lower eukaryotes such as fungi and plants the use of His-to-Asp signal 
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transduction systems are also quite abundant [9-11]. Activation of these pathways often 
results in the regulation of gene expression directly, or through regulation of other 
downstream pathways [12]. Table 1 gives examples of histidine-to-aspartate 
phosphorelay systems in various organisms. 
 
1.2 Histidine-to-aspartate systems in prokaryotes 
As the name implies, His-to-Asp two-component systems generally consist of 
two distinct protein components; an often membrane bound histidine kinase (HK) and 
a downstream response regulator (RR) (Figure 1A) [13, 14]. While bacteria often 
Table 1. His-to-Asp phosphorelay systems 










Escherichia coli CpxA --- CpxR 
Regulation of protein 
trafficking factors 
  Escherichia coli CheA --- CheY Chemotaxis 
  Bacillus subtilis Spo0F Spo0B Spo0A Sporulation 
  Pseudomonas aeruginosa NarX --- NarL Nitrogen respiration 
  Vibrio harveyi LuxN/LuxQ --- LuxO Luminescence 
 
 
Salmonella typhimurium PhoP --- PhoQ 
Virulence and macrophage 
survival 
  Caulobacter crescentus Ccka ChpT CtrA Cell cycle progression 
  Bordetella pertussis BvgS --- BvgA Virulence 
  Myxococcus xanthus RedC RedE RedF Cell cycle/development 
  Streptococcus pneumoniae CiaH --- CiaR Beta-lactam resistance 
 Eukaryotes 
  Schizosaccharomyces pombe Mak2/3 Mpr1 Msc4 Oxidative stress 
  Saccharomyces cerevisiae Sln1 Ypd1 Ssk1 Osmotic stress 
  Candida albicans Nik1/Chk1/Sln1 Ypd1 Ssk1 Stress repsonse 
 
 
Arabidopsis thaliana AHK5 AHP1,2,5 ARR4,ARR7 




Cryptococcus neoformans Tco1,Tco2 Ypd1 Ssk1 




 Halobacterium salinarum VicK --- VicR Temperature sensing 
  Methanosaeta harundinacea FilI --- FilR methanogenesis 
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contain numerous two-component systems, each individual system generally consists 
of a single HK and RR cognate pair clustered with in the same operon as proteins of 
similar function [8]. 
 
HKs are multi-domain proteins with a minimum of two domains, an input (or 
sensory) domain and a cytoplasmic catalytic kinase domain [15]. Sensory domains of 
HK proteins are highly variable in structure and function due to the necessity of sensing 
a wide variety of external stimuli [16-20].  For example, for the membrane bound HK 
from Enterococcus faecalis FsrC, binding of the small peptide ligand gelatinase 
biosynthesis-activating pheromone (GBAP) results in regulation of quorum sensing 
genes which are important for virulence [21]; for the HK CusS in Escherichia coli, 
 
Figure 1. Histidine-to-Aspartate phosphorelay systems 
A. Canonical two-component system. Consists of a membrane bound HK and cytoplasmic RR. ATP 
is used as a phosphoryl donor during HK autophosphorylation on a conserved histidine. The 
phosphoryl group is then transferred to an aspartate residue on a downstream RR. Phosphorylation 
of the RR leads to protein activation which results in a cellular response.  
B. Multi-step His-to-Asp phosphorelay system. Consists of an HHK, an HPt and an RR. 
Autophosphorylation occurs in a conserved histidine of the HHK, the phosphoryl group and is 
then transferred to a conserved aspartate in the receiver domain of the HHK.  The phosphoryl 
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CusS directly binds silver ions and undergoes a conformational change which activates 
kinase activity and results in gene expression of the CusCFBA efflux pump [22].  
Ligand binding, whether a  small molecule or in the form of another protein, results in a 
structural rearrangement of the HK from an “inactive” to an “active” conformation, at 
which point nucleotide binding and autophosphorylation occur.  
Because the sensory domain is highly variable, HK proteins are classified 
according to their cytoplasmic domain architecture. Currently there are three structural 
classes of HK proteins: Class 1 HKs contain an extra-cytoplasmic sensory domain that 
senses external stimuli and transmits the signal across the membrane; Class 2 HKs lack 
an apparent extra-cytoplasmic domain and the sensing region is thought to be the trans-
membrane domains themselves; Class 3 HKs are characterized by a single cytoplasmic 
sensory domain [23].  
Unifying structural features found in the cytoplasmic region of all HK proteins 
include a dimerization and histidine phosphotransfer (DHp) domain and a C-terminal 
catalytic and ATP binding domain (CA). There are five conserved “boxes” which 
contain characteristic amino acid sequences. In the DHp domain, the H-box contains 
the phospho-accepting histidine residue, while in the CA domain the Nl, Gl, G2 and F 
boxes are involved in ATP-dependent autophosphorylation and nucleotide binding [5, 
24].   
Generally, two monomeric subunits dimerize to form the DHp domain. 
Structural information available about the DHp domain demonstrates a conserved 4 α-
helix bundle [25-28]. From the X-ray crystal structure of the entire cytoplasmic region 
of the class I HK, HK853 from Thermotoga maritima (PDB 2C2A), both the core four 
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α-helix bundle forming the DHp domain as well as the catalytic kinase domain are 
observed  [29]. The phosphorylatable histidine residue (H260) found in the DHp 
domain is shown to be completely solvent exposed and bound to a sulfate ion which is 
believed to act as a phosphoryl mimic. The C-terminal CA domain shows a 
characteristic α/β sandwich fold composed of three α-helices packed against five 
antiparallel β-strands.  The bound ADP molecule shows where nucleotide binding 
occurs (Figure 2) [29]. The structure of HK853 reveals that nucleotide binding occurs 
between 2 loops in the catalytic domain (Figure 2). Typically this nucleotide is held in 




Figure 2. Crystal structure of the cytoplasmic portion of HK853 from T. 
maritima  
Ribbon diagram of the homodimeric HK853 (PDB ID: 2C2A) shows how the monomers (one 
monomer colored blue and one monomer colored red) dimerize to for a DHp domain to form of a 
core four alpha-helix bundle.  Phosphorylatable histidine residues are completely solvent exposed and 
with a bound sulfate ion which mimics a phosphoryl group (shown in stick representation).  The CA 
domain shows a bound ADP molecule and a conserved α/β sandwich fold.  
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 HK autophosphorylation involves transferring the γ-phosphate from ATP to the 
Nε atom of the catalytic histidine to form a high energy N~P bond [15].  
Autophosphorylation can either occur in cis or trans fashion. Cis autophosphorylation 
occurs when the catalytic site on one monomer catalyzes the phosphorylation of the 
histidine residue on the same monomer, while in trans autophosphorylation the 
catalytic domain of one monomer catalyzes the phosphorylation of the histidine on the 
other monomer of the homodimer [15].   
Once ATP-dependent autophosphorylation of the HK occurs, the phosphoryl 
group is transferred to a conserved aspartate residue found in the receiver domain of a 
downstream RR (Figure 1A).  For phosphotransfer to occur between HK and RR, a 
divalent metal ion, most often magnesium, must be present in the active site of the RR. 
It is responsible for neutralization of charged acidic residues found in the active site 
[30-32]. The aspartate residue acts as a nucleophile and attacks the positively charged 
phosphorous on the phosphoryl group 
attached to the histidine. Phosphorylation of 
the RR often results in dimerization and the 
protein is in an “activated” form. 
An overall conserved architecture has 
been observed from crystal structures of 
receiver domains from various RR proteins 
[33-40]. From the crystal structure of CheY 
from E. coli (PDB ID: 1A0O), a central five-
stranded parallel β-sheet can be seen 
 
Figure 3. Crystal structure of 
the response regulator CheY 
Ribbon diagram from crystal structure of 
the RR protein CheY from E. coli (PDB 
ID: 1A0O). Receiver domains from RR 
proteins have a conserved (α/β)5 
topology. The phospho-accepting 
aspartate is shown in stick representation 
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surrounded by five amphipathic α-helices (Figure 3). The phospho-accepting aspartate 
residue is located on the end of the third beta strand [41].  
RR proteins commonly contain two domains, a receiver domain, where the 
conserved aspartate residue is located, and an effector domain. The effector domain is 
variable in sequence and in structure, but frequently contains a DNA binding domain 
[42]. Function of RR proteins vary greatly depending not only on the stimulus from the 
HK, but also on the function of the effector domain. RR protein activation can result in 
activation of many functions, such as stress response [43-46] gene regulation involved 
in cell cycle progression [47-51], virulence [52-58] and biofilm formation [59-61].  
1.3 Expanded two-component systems in bacteria  
While the canonical two-component system model in bacteria shows that these 
phosphotransfer systems generally consist of two proteins, there are many examples of 
expanded systems [62-64]. Surveys on bacteria with completely sequenced genomes 
have indicated that a large number of non-canonical histidine-to-aspartate multi-step 
systems exist [65]. These systems can consist of an HK or RR with additional protein 
domains, resulting in “hybrid” proteins. Often a histidine phosphotransfer domain (HPt) 
is the additional domain present. The anaerobic sensor kinase ArcB found in a two-
component system in Escherichia coli, has three domains, an HK domain, a receiver 
domain, and an HPt domain [66].  Additional stand-alone proteins are also found in 
specific pathways. For example, in the bacteria Myxoccocus xanthus, a “four-
component system” is present [67]. Results from numerous studies have indicated that 
when multi-step systems are present in prokaryotes, they are found in organisms with 
distinct characteristics, such as cyanobacteria, pathogenic bacteria, or bacteria with 
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unusual life-cycle switching mechanisms [68]. This modularity is thought to allow for 
an increased versatility in signaling by allowing for a wider variety of output signals 
and more stringent regulation. 
1.4 Histidine-to-aspartate two-component systems in eukaryotes 
 The original discovery of His-to-Asp pathways in eukaryotes occurred in 1993 
when ETR1 in Arabidopsis thaliana and Sln1 in Saccharomyces cerevisiae were 
revealed [68, 69]. Prior to 1993 it was believed that eukaryotic organisms only 
contained the more “typical” phosphotransfer systems that involve threonine, serine, 
and tyrosine phosphorylation. When eukaryote genomes were further examined, it was 
shown that these pathways were not as uncommon as previously thought. However, 
unlike bacteria, eukaryotic His-to-Asp signaling most often consists of expanded multi-
step pathways.  
In these multi-step His-to-Asp signaling pathways, the sensor kinase has 
evolved to become a hybrid histidine kinase (HHK). This kinase, which contains both 
the sensor and effector domains found in canonical HK proteins, also contain their own 
receiver domain [68, 70]. These HHKs are highly diverse and often contain additional 
domains, such as GAF, PAS and HAMP domains [71]. ATP dependent 
autophosphorylation occurs at the conserved histidine residue, but instead of the 
phosphoryl group being transferred to a receiver domain of a downstream RR protein, it 
is transferred to a conserved aspartate residue in its own receiver domain (Figure 1B). 
In order to maintain the histidine-to-aspartate signal transduction scheme, an additional 
stand-alone protein, a histidine phosphotransfer protein (HPt), is found as an 
intermediate between the HHK and the RR.   
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HPt proteins are generally small and often have low sequence homology to other 
HPt domains and stand-alone HPt proteins except in the region surrounding the 
conserved phosphorylatable histidine, which appears to be highly conserved [72]. They 
play a crucial role in regulating cellular functions of bacteria, eukaryotes and plants [5, 
70, 73].  HPt domains or stand-alone proteins share a common structural motif, a four 
α-helix bundle as a core structure, with the conserved phospho-accepting histidine 
residue exposed to solvent [72, 74, 75].  From the crystal structure of Ypd1 (PDB ID: 
1QSP), an HPt from S. cerevisiae, a conserved four helix bundle is observed similar that 
that seen in the DHp domain of HK proteins [28, 76].  
 
In addition to the HPt protein, a second RR protein is often present in eukaryotic 
pathways [77]. As with prokaryotic systems, the RR often contains a DNA binding 
domain and is responsible for enhancing or suppressing gene expression. However, 
 
Figure 4. Crystal structure of histidine containing phosphotransfer protein 
ScYpd1 from Saccharomyces cerevisiae 
Ribbon diagram of the HPt protein ScYpd1 (PDB ID: 1QSP). The protein is composed of the core 
four-helix bundle which is surrounded by 2 additional small helices. Phospho-accepting histidine 
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because of the compartmentalization of cellular organelles in eukaryotic organisms, RR 
proteins are sequestered from each other, generally with a single RR protein located in 
the cytoplasm, and another located in the nucleus [42, 78].  In the fungal pathogen 
Candida albicans a third RR protein, Srr1, was discovered to be localized in the 
mitochondria [79].  
In yeast and fungi, these His-to-Asp multi-step pathways have been shown to be 
responsible for both upstream regulation of the serine/threonine/tyrosine 
phosphotransfer cascades as well as direct regulation of gene expression. Until recently, 
elucidation of these eukaryotic pathways has mainly focused on ascomycetes such as 
Saccharomyces cerevisiae, Candida albicans, and Aspergillus fumigatus, as well as 
pathogenic organism such as the basidiomycete fungi Cryptococcus neoformans. 
However, with increased genetic data available studies of more species is rapidly 
increasing. 
Recently, studies of proteomic data available have revealed that some species 
encode very large expansions of HK and RR gene families [74, 80]. Filamentous fungi 
have been reported to have as many as 18 HK proteins, and plant species have been 
shown to have as many as 8.  In addition to the HK proteins, these eukaryotes also have 
larger numbers of RR proteins [9].  Although in general, fungi are typically shown to 
have only one HPt protein present, several plant species encode multiple HPts [9]. This 
may be due to the more diverse sensing activities of these higher eukaryotes as well as 
activities related to pathogenesis. 
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1.5 Research focus 
My research has focused on better understanding the HPt proteins found in two 
eukaryotic organisms, Ypd1 homologs from the “baker’s yeast” Saccharomyces 
cerevisiae and the human fungal pathogen Cryptococcus neoformans. While the 
hyperosmotic stress pathway in S. cerevisiae has been extensively studied [81, 82], 
there are still questions that we would like to address. One residue, G68 located at the 
H+4 position relative to the phosphorylatable histidine on the surface of ScYpd1, has 
been shown to have a greatly diminished phosphotransfer ability to ScSsk1 relative to 
wild-type levels of phosphotransfer [83]. This residue is located near the active site of 
the protein near a series of small residues, and is hypothesized to be required for proper 
protein-protein interactions with its binding partner. Bioinformatics was used to 
elucidate the exceedingly high conservation of a glycine in this H+4 position. A series 
of point mutants were constructed and analyzed using phosphoryl transfer assays, 
fluorescence-based binding assays, X-ray crystallography and molecular dynamics 
techniques. This work was completed as a lab collaboration and will help to elucidate 
why this particular residue is of seemingly high important for protein function.   
Very little is currently known about the biochemistry involved in the His-to-Asp 
multi-step signal transduction pathways that are found in C. neoformans. All 
information available to date regarding these pathway has been obtained through 
genetic studies and complementation in vivo experiments [84, 85]. My objectives were 
to further characterize the CnYpd1 phosphotransfer protein. The site of phosphorylation 
was confirmed, CnYpd1 was analyzed for functional differences distinct from other HPt 
proteins, such as structural, oligomeric state, and phosphorylated protein stability. 
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According to sequence alignments, CnYpd1 contains an extended N-terminal. 
Homology models have not yielded any information about what possible function of the 
N-terminal region may confer to the protein. Mutation studies, phosphotransfer assays, 
size exclusion chromatography assays, and ICP-MS were used to try to address these 
questions as well as to investigate the possible function of the N-terminal region.  
1.6 Significance 
Further studies of the functions and mechanisms of His-to-Asp signal transduction 
pathways will allow for a greater understanding of how organisms use these pathways 
are used to respond to stresses and control virulence.  
For all signal transduction pathways, proteins must interact with each other in order 
to elicit the proper response. For branched pathways, such as those found in S. 
cerevisiae and C. neoformans, proteins must be able to distinguish between multiple 
binding partners. In both S. cerevisiae and C. neoformans, the HPt protein Ypd1 is 
found at a crucial branch point of the pathway, and has a fundamental role in 
determining which downstream RR protein should be activated through 
phosphotransfer. The basis of this activation has to be in the form of a proper response 
to the type of external stimuli that was sensed by the HHK protein. Further 
understanding of how specificity is conferred by the HPt would greatly further our 
understanding of how these branched signal transduction pathways function. 
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Role of the highly conserved G68 residue in the yeast phosphorelay 
protein Ypd1: implications for interactions between histidine 
phosphotransfer and response regulator proteins 
1.1 Introduction 
Histidine phosphotransfer (HPt) proteins allow bacteria, yeast and plants to 
expand beyond canonical two-component signaling pathways into multi-step 
phosphorelay pathways. They play crucial roles in regulating numerous cellular 
functions including those essential for growth and viability [1-4]. In bacteria, HPt 
domains are found as additional domains in two-component signaling proteins [5-7]. In 
fungi and plants, HPts are often stand-alone proteins occupying branch points within 
multi-step His-to-Asp phosphorelays [8-11].  
Multi-step phosphorelay systems consist of the transmembrane hybrid histidine 
kinase (HHK), an HPt protein, and often multiple downstream response regulators 
(RR). The multi-step His-to-Asp phosphorelay Sln1 pathway of Saccharomyces 
cerevisiae (Sc) has been extensively studied [12-16]. The ScSln1 hyperosmotic stress 
pathway consists of the transmembrane HHK protein ScSln1, the HPt protein ScYpd1, 
and two RR proteins ScSsk1 and ScSkn7 (Figure 5) [11, 17, 18]. While ScYpd1 is 
activated by a single upstream donor, it can phosphorylate both ScSsk1 and/or ScSkn7 
depending on the encountered stress. ScSsk1 is responsible for osmotic stress response 
through the High Osmolarity Glycerol (HOG1) Mitogen Activated Protein Kinase 
(MAPK) pathway, while activation of ScSkn7 is in response to cell wall stress [19]. 
ScSkn7 functions through direct transcriptional regulation of cell wall genes [20, 21].  
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ScSln1 is a membrane-bound 
HHK. Under normal osmotic conditions, 
ScSln1 autophosphorylates on a conserved 
histidine residue, H576, by transfer of the 
γ-phosphoryl group from ATP; this 
autophosphorylation leads to transfer of 
the phosphoryl group to a conserved 
aspartate residue, D1144, in its own 
receiver domain [11].  
Much is known regarding the 
structure/function relationship between the 
individual domains of ScSln1.  ScSln1 has 
been shown to be evenly distributed 
throughout the cytoplasmic membrane, but 
rapidly clusters is response to hyperosmotic stress [22]. Systematic deletions mutants 
have shown that the periplasmic domain is essential for ScSln1 function [22]. A coiled-
coil “linker” domain found between the transmembrane domains and the cytoplasmic 
 
Figure 5. Sln1-Ypd1-Ssk1/Skn7 
pathway in S. cerevisiae  
ScSlnl is autophosphorylated on a histidine 
residue using ATP, this phosphoryl group is 
then transferred to an aspartic acid residue in 
the receiver domain of ScSlnl, and then to a 
histidine residue in ScYpdl. Subsequent 
phosphotransfer occurs to ScSsk1 or ScSkn7. 
Phosphorylated ScSskl serves to suppress the 
activation of the Hog1 MAP kinase pathway, 
while phosphorylated Skn7 regulates the 
expression genes related to cell wall stress.  
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kinase domain has also been shown to be 
essential for ScSln1 to function as an 
osmosensor [23] (Figure 6). After 
autophosphorylation, ScSln1 must pass the 
phosphoryl group from the reciever domain 
aspartate, D1144, to the a conserved histidine 
residue, H64, on the HPt protein ScYpd1.  
The crystal structure of ScYpd1 revealed 
the same highly conserved fold found in other 
HPt structures [24, 25]. The ScYpd1 structure 
shows a common four-helix bundle core. The 
core is highly hydrophobic, and is protected 
from solvent by an extended linker region, the 
EF-linker [25].  The site of phosphorylation is 
completely solvent exposed  and easily accessible for interaction with the reciever 
domains of its RR binding partners. Crystal structures of the receiver domain of ScSln1 
in complex with ScYpd1 have helped to elucidate protein-protein interactions between 
HHK proteins and HPt proteins (Figure 7) [26, 27].  The structure revealed a buried 
hydrophobic patch surrounded by hydrophilic interactons, which may be distinct 
between different HPt:RR binding partners [26]. 
 
Figure 6. ScSln1 domain 
architecture 
ScSln1 functions as a homodimer and is 
composed of multiple domains. The 4-
helix bundle is composed of two 
domains from each monomer and is the 
location of the phosphorylatable 
histidine residue. The catalytic kinase 
domain is the binding site for ATP. The 
receiver domain is the location of the 
phosphorylatable aspartate residue.  
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Under normal osmotic conditions, the ScSln1-ScYpd1-ScSsk1 branch of the 
pathway is constitutively phosphorylated, and the downstream HOG1 pathway is 
repressed.  Under hyperosmotic stress, ScSln1 ceases to autophosphorylate, allowing 
dephosphorylated ScYpd1 and ScSsk1 to accumulate. Unphosphorylated ScSsk1 is able 
to interact with the auto-inhibitory domain of ScSsk2/22, the most upstream component 
of the Hog1 MAPK cascade [17] and activate the pathway. Autophosphorylation of 
ScSsk2/ScSsk22 (MAPKKK) leads to phosphoryl group transfer to ScPbs2 (MAPKK) 
and finally transfer to ScHog1 (MAPK) [28]. Phosphorylated ScHog1 will then migrate 
into the nucleus and initiate expression of genes to respond to the loss of turgor 
pressure, which includes production of the compatible osmolyte glycerol [29-31] .  
 
 
Figure 7. Crystal structure of complex between ScSln1-R1 and ScYpd1 
The BeF3- activated complex of ScSln1-R1 (purple) and ScYpd1 (blue) demonstrates how the protein 
components interact with one another to form a complex for phosphotransfer to occur (PDB ID: 2R25). 
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The ScSln1 pathway is required for cell viability through regulation of the ScHOG1 
pathway [11, 17, 32]. Defects affecting any step of the ScSln1 pathway compromise the 
yeast’s ability to respond to osmotic stress, leading to decreased cell viability. 
Previous studies of the ScSln1 pathway using yeast two-hybrid assays and X-ray 
crystallography showed that ScYpd1 interacts with the receiver domains of its response 
regulator binding partners using a common hydrophobic binding surface [33, 34].  All 
known structures of HPt proteins, including S. cerevisiae ScYpd1, share a characteristic 
4-helix bundle structure with this common hydrophobic binding surface [25, 35-40].  
The phosphorylatable histidine residue is located just below this hydrophobic patch on 
the αC helix of the 4-helix bundle and is completely solvent-exposed [1, 41].  
Despite their remarkably similar tertiary structure, HPt domains exhibit high 
sequence diversity.  However, sequence conservation exist near the phosphorylatable 
histidine, including much of the αC helix. Conserved intramolecular interactions pull 
the side chains of nearby residues N61 and K67 of ScYpd1 away from the histidine 
leaving it accessible to the active site of cognate response regulators [38, 41, 42]. 
Phosphorylated half-life studies of ScYpd1 suggest that these residue may also be 
involved in the electrostatic stabilization of the phosphorylated histidine [27, 43].  
A glycine located four residues from the phosphorylatable histidine (H+4), is 
highly conserved on the surface of HPt proteins, and has been shown to be involved in 
protein-protein interactions and/or phosphoryl transfer in both yeast and bacteria [33, 
44-47]. Mutation of the H+4 glycine in ScYpd1-G68Q was shown to have impaired 
binding of all RR receiver domains in an alanine scanning yeast two-hybrid assay [33].  
The ability of the ScYpd1-G68Q to both accept and transfer phosphoryl groups was 
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severely impaired [44, 45]. Kinetic analysis shows that while there was a dramatic 
decrease in the rate of phosphoryl transfer between ScSln1-R1 and ScYpd1-G68Q, 
binding affinity remained similar to WT [44], indicating that the phenotypic changes 
observed during phosphotransfer may be related to catalysis and not a binding defect.  
 In order to further characterize the role that the H+4 residue plays in protein-
protein interactions between ScYpd1 and ScSsk1, a series of amino acids substitutions 
were made to the H+4 glycine.  This work was completed as a collaborative project 
with several individual members completing different aspects of the project. Here we 
report a comprehensive analysis of a set of point mutants at position 68 of Ypd1 to gain 
insights into the evolutionary constraints leading to the exceptionally high conservation 
of glycine at position H+4 in HPts. We combine bioinformatics, phosphoryl transfer 
assays, X-ray crystallography, a fluorescence-based binding assay and molecular 
dynamics techniques to help explain the delicate balance of interatomic interactions 
required for phosphotransfer to occur between an HPt and its cognate RR. The 
conclusions that can be drawn clarify the importance of a small and/or hydrophilic 
residue in the H+4 position. 
1.2 Materials and Methods 
1.2.1 Cloning 
 
For expression of wild-type ScYpd1, the ScYPD1 gene was inserted into a 
modified pUC12 vector (pME43) as previously described [42]. The pUC-ScYPD1 
plasmid was then used as a template to construct a set of ScYpd1-G68X mutants using 
site-directed mutagenesis PCR (primers listed in Table 12 in Appendix A). Various 
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amino acid residues (S, A, V, L, E, Q) were introduced to the G68 position. For the 
PCR reaction, the denaturation temperature was set to 95°C for 1 minute, the annealing 
temperature was set to 55°C for 1 minute, and the extension temperature was set to 
72°C for 7 minutes for 12 cycles. 
The ScYPD1 gene was also inserted into a pET21a (+) vector for expression 
using the T7 promotor. To covalently attach a fluorescein molecule in close proximity 
of the active site of ScYpd1, T12 was mutated to a cysteine residue (ScYpd1-T12C) 
through two-step PCR site-directed mutagenesis. The resulting plasmid was then used 
as a template for creation of double mutants.  
The expression vector encoding the ScSln1 kinase domain (GST-ScSln1-HK), 
was kindly provided by R. Deschenes (University of South Florida). 
1.2.2 Protein purification 
 
All ScYpd1 protein constructs used in this study were expressed in Escherichia 
coli, either DH5α for the constructs in pUC vectors, or BL21 (DE3) Star cells for 
constructs in the pET21a vector.   
Proteins were purified by ammonium sulfate precipitation, anion exchange 
chromatography, and size exclusion chromatography as described previously with slight 
modifications [45].  The final size exclusion chromatography buffer used for the 
phosphotransfer reactions was modified to be 20 mM Tris-HCl pH 8.0 with 150 mM 
NaCl.   
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GST-ScSln1-HK was expressed and purified as a glutathione S-transferase 
(GST) fusion protein using glutathione Sepharose 4B resin. Protein was stored and used 
in assays in bead-bound form, as previously described [18].  
The receiver domain from ScSln1 (ScSln1-R1) and the receiver domain of 
ScSsk1 (ScSsk1-R2) were inserted into a pFJS16 vector, as previously described [48]. 
These proteins were expressed in E. coli Rosetta (DE3) cells (Novagen) as a fusion 
protein containing C-terminal intein and chitin binding domains and was purified by 
chitin affinity chromatography and gel filtration, as described previously [18, 48]. 
1.2.3 Sequence alignment 
 
Pfam was used to identify all sequences within the NCBI database containing an 
HPt domain, including both stand-alone HPt proteins and proteins with distinct HPt 
domains [49, 50]. This sequence list was edited with Jalview to remove redundancy 
(with a 98% cut-off) and duplicates were deleted to remove species bias.  The number 
of non-redundant sequences remaining was found to be approximately 12000. 
Sequences were then sorted and counted based on residues in the H+4 position. Jalview 
was used to construct a representative sequence alignment of HPts from various 
domains of life [51]. 
1.2.4 In vitro phosphorylation assay 
 
The ScSln1-HK domain bound to glutathione-Sepharose 4B resin was 
phosphorylated via incubation with 0.66 μM [γ-32P]-ATP (3000 Ci/mmol) for 30 min 
according to previously published protocols [14]. Unincorporated [γ-32P]-ATP was 
washed from phospho~ScSln1-HK with 50 mM Tris-HCl, pH 8.0, 100 mM KCl, 15 
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mM MgCl2, 2 mM DTT, and 20% glycerol by three consecutive centrifugations (1 min 
at 1000g). ScSln1-R1 was added to the reaction and incubated for 5 minutes with 
ScSln1-HK. ScSln1-HK was removed from the reaction through gentle centrifugation, 
leaving only ScSln1-R1 in solution. ScSln1-R1 was then used as a donor to 
phosphorylate all ScYpd1 proteins. ScYpd1 proteins were phosphorylated by incubation 
with an equimolar concentration of Sln1-R1 for 5 minutes.  To test the ability of the 
ScYpd1-G68X mutants to transfer the phosphoryl group to downstream binding 
partners, ScYpd1~P was incubated with an equimolar concentration of ScSsk1-R2 and 
an aliquot was obtained at 5 minutes. Band intensities were quantified using ImageJ 
[52]. 
1.2.5 Fluorescence-based affinity assay (assay performed by Skyler Hebdon) 
 
A mutation was made to ScYpd1 T12, adjacent to the hydrophobic binding 
patch, to introduce a unique, solvent exposed cysteine for thiol-specific labelling with a 
fluorescent probe. ScYpd1-T12C and ScYpd1-T12C-G68X mutants were purified 
according to the already published Ypd1 purification protocols [25] and buffer-
exchanged into 50 mM potassium phosphate pH 9.0 and 1mM β-mercaptoethanol. 
Proteins were incubated in darkness for 2 hours at room temperature with a 7-fold molar 
excess of 5-iodoacetamidofluorescein (5-IAF) for covalent labeling of T12C. 
Unincorporated 5-IAF was removed by exchanging labelled ScYpd1 proteins into 20 
mM Tris pH 8.0, 50 mM NaCl and 10 mM MgCl2 using a GE HiTrap desalting column.  
The concentration of bound fluorescein was estimated by absorption at 492 nm, and 
protein concentration was estimated by BioRad protein assay revealing that 70-90% of 
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the ScYpd1 molecules were labelled. Fluorescently-labeled proteins were aliquoted and 
stored in the presence of 10% glycerol at -20 ˚C until ready for use.  
ScSln1-R1 receiver domain as purified as described previously, but size 
exclusion was performed in fluorescence buffer (20 mM Tris pH 8.0, 50 mM NaCl and 
10 mM MgCl2). Chelex® resin (BioRad) was used to strip contaminating cations from 
the Tris-salt solution before magnesium chloride was added to the buffer.  
Binding of Sln1-R1 to fluorescein labelled ScYpd1-T12C induces a change in 
the molar extinction of the fluorescein moiety. A Fluoromax 4 Spectrofluorometer from 
Horiba Scientific, temperature controlled to 23.0 °C, was used to observe changes in 
fluorescence caused by binding. 30 pmol of labelled ScYpd1-T12C was diluted to 1,900 
μL in fluorescence buffer, and ScSln1-R1 was titrated into the reaction such that the 
concentration in the cuvette ranged from 10 nM to 6 μM. Upon addition of ScSln1-R1, 
the mixture was stirred with a magnetic stir bar for 30 seconds and allowed to rest for 
an additional 20 seconds before reading fluorescence intensity with absorbance at 492 
nm and emission at 515 nm. Intensity after each addition (F) as a fraction of intensity 
from labelled ScYpd1 alone (F0) was calculated for titration with ScSln1-R1 and buffer 
alone. The difference between these two normalized intensities (F/F0, Sln1-R1 - F/F0, 
buffer) indicates binding of ScSln1-R1 to labelled ScYpd1. Plotting change in 
fluorescence intensity caused by ScSln1-R1 versus concentration of ScSln1-R1 shows a 
binding curve with saturation at high concentrations. These curves were fitted using 
Mathematica to an expanded quadratic equation with parameters accounting for 
fluorescence from both the bound and unbound states of ScYpd1 and the dissociation 
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constant for the ScYpd1: ScSln1-R1 complex. The average dissociate constant and 
standard deviation of the mean are reported here.    
1.2.6 Crystallization (structure determination completed by Dr. Smita Menon) 
 
Hexagonal form ScYpd1-G68Q mutant crystals were grown using conditions 
obtained for wild ScYpd1 [42], a protein concentration of 10 mg/mL was used in a 0.1 
M sodium acetate pH 5.0 buffer with 0.2 M ammonium acetate and 25-30% PEG 4000 
(Fluka, 81242).  
1.2.7 X-ray data collection and processing 
 
Data were collected at the home source (OU Macromolecular Crystallography 
Lab) using CuKα radiation from a Rigaku Micromax 007HF X-ray generator set to 1.54 
Å wavelength at 100 K by flash freezing crystals in a liquid N2. High concentrations of 
PEG 4000 were used as a cryoprotectant. The data were recorded with a Dectris Pilatus 
P200K hybrid pixel detector using oscillations of 0.5° and processed using HKL2000 
[53]. The space group was determined to be P3121 after inspection of the electron 
density maps. The unit cell was determined to be a = b = 76.7 Å, c = 66.7 Å α = β = 
90˚, γ = 120˚. One molecule was found in the asymmetric unit with a resolution of 1.98 
Å.  Data processing and refinement statistics are presented in Table 1. 
1.2.8 Structure solution and refinement 
 
Molecular replacement using PHASER-MR from the Phenix (vs. 1.10pre_2131) 
[54-56] suite of programs was used to determine the initial phases using WT-ScYpd1 
structure (1QSP) [42]. Refinement was carried out using Phenix-refine [57]. Clear 
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electron density difference was seen for the glutamine side chain at position 68 in a Fo-
Fc electron density map. Coot [58] was used to place the glutamine into the electron 
density map and manually adjust the model after each cycle of refinement. The final the 
Rwork was 17.1% with an Rfree of 20.4%. 
 
 
1.2.9 Molecular dynamics simulations (simulations performed by Clay Foster) 
 
ScYpd1-G68X mutations were modeled using PyMOL version 1.83. For 
ScYpd1-G68Q and G68E (unpublished data), crystal structures were aligned to the 
existing Sln1-R1/Ypd1-BeF3
- complex (PDB ID: 2R25). The mutant ScYpd1 and 
ScSln1-R1 molecules were then extracted for simulation. For the remaining 
substitutions, mutations were modeled directly onto the ScYpd1: ScSln1R1 activated 
structure (PDB ID: 2R25). In each model, the BeF3
- ligand was replaced by PO3
2-. Each 
system was stripped of crystallographic waters and ligands, with only the Mg2+ 
remaining at the active site. Structures were then placed in an orthorhombic solvent box 
using the TIP3P model. Finally, systems were neutralized and set to a concentration of 
0.15 M NaCl. System preparation and visualization were done using Schrodinger 
Maestro [59]. Simulations were performed with Desmond using the OPLS 2005 force 
field [60, 61]. The default Desmond relaxation protocol was used, featuring a series of 
gradually diminishing restraints for ~270 ps, followed by a brief, 100 ps unrestrained 
NPT simulation. To preserve the pre-phosphotransfer active site and the relative 
locations of the phosphorylatable histidine and aspartate, a position restraint with a 
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force constant of 100 kcal/mol/Å was applied to the Nε2 atom of H64 and the 
phosphoryl during each simulation. Final structures were examined using PyMOL [62]. 
1.2.10 Molecular graphics 
 
All molecular figures were generated using PyMOL version 1.83 [62]. 
1.3 Results  
1.3.1 A glycine in the H+4 position of HPt domains and stand-alone HPt proteins 
is highly conserved  
 
 
Figure 8. Representative sequence alignment of HPt proteins or domains from 
fungi, plants and bacteria   
Representative sequence alignment of the αC region of stand-alone HPt proteins or HPt domains from 
fungi, plants and bacteria.  The phosphorylatable histidine residue is highlighted in red and the H+4 
residue is highlighted in blue. 
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Approximately 12000 non-redundant 
sequences in the NCBI database representing 
bacteria, fungi and plants were analyzed. The 
region spanning the predicted αC and αD 
helices of the core 4-helix bundle found in HPt 
proteins, as well as hybrid proteins containing 
HPt domains, was used to construct the 
alignment. Glycine was found to be present in 
~85% of sequences that were aligned. The 
second most abundant amino acid at this 
position was found to be serine, which 
represented ~12% of sequences analyzed, 
followed by proline with ~1% (Table 2). A representative sequence alignment of the 
highly conserved region of HPt protein with the phosphorylatable histidine residue 
highlighted in red and the H+4 glycine highlighted in blue is shown in (Figure 8). 
 
  
Table 2. Quantification of 
residues found in the H+4 





% of Total 
G 10071 84.96  
S 1392 11.74  
P 115 0.970  
A 92 0.77  
T 72 0.60  
N 42 0.35  
H 22 0.18  
E 11 0.09  
V 10 0.08  
R 10 0.08  
I 6 0.05  
C 2 0.01  
D 2 0.01  
L 2 0.01  
Q 2 0.01  
W 1 0.008  
Y 1 0.008  
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1.3.2 Non-conservative mutations at ScYpd1 G68 disrupt phosphotransfer 
 
Phosphorelay experiments were 
performed on each of the G68X mutants 
using ScSln1-R1 as a phospho-donor and 
ScSsk1-R2 as a phospho-recipient. 
ScYpd1-G68S and ScYpd1-G68A were 
both able to accept a phosphoryl group 
from ScSln1-R1 with approximately the 
same ability as wild-type ScYpd1 (Table 3). All other mutants showed various 
decreased levels of phosphorylation.  Briefly, ScYpd1-G68Q showed a drastic decrease 
in its ability to accept a phosphoryl group (~40% of wild-type). ScYpd1-G68V, 
ScYpd1-G68L, and ScYpd1-G68E were almost completely unable to accept a 
phosphoryl group from ScSln1-R1 (Figure 9).  
 
Full phosphorelay experiments were performed between ScSln1-R1, the set of 
ScYpd1-G68X mutants and ScSsk1-R2. ScYpd1-G68S and ScYpd1-G68A were able to 
 
Figure 9. Phosphoryl transfer from phosopho~ScSln1-R1 to ScYpd1 
Phosphoryl transfer reactions contained equimolar concentrations of ScSln1-R1 and ScYpd1. 
Reaction was quenched at 5 mins. The autoradiographs were analyzed using ImageJ and the 
amount of radiolabel in ScYpd1-G68X mutants was quantified and compared with the amount of 
radio-label seen for the wild-type ScYpd1 band (set to 100%). 
 
Table 3. Ability of ScYpd1-G68X 









WT 100 ± 0 100  ± 0 
G68S 94.1± 3.6 80.9  ± 17.8 
G68A 82.0 ± 15.6 80.4  ± 8.0 
G68V 2.5 ±3.5 0.36  ± 0.6 
G68L 0.4 ± 0.6 0.28  ± 0.5 
G68E 0.3 ± 0.5 0.08  ± 0.15 
G68Q 40.2 ± 8.3 0.9  ± 1.6 
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transfer a phosphoryl group to ScSsk1-R2 comparable to wild-type ScYpd1.  Severe 
impairment of the ability of phospho~ScYpd1-G68Q to transfer the phosphoryl to 
ScSsk1-R2 was observed (Figure 10), consistent with previously published results [45]. 
Due to their inability to accept an initial phosphoryl group, no transfer could be 
observed between ScYpd1-G68V, ScYpd1-G68L and ScYpd1-G68E mutants and 
ScSsk1-R2. 
 
1.3.3 Substitutions at the G68 position cause only modest changes in affinity of 
ScYpd1 for ScSln1-R1 (Experiments performed by Skyler Hebdon) 
   
Because a defect was observed in the ability for ScYpd1 to accept phosphoryl 
groups, a fluorescence based, in vitro binding assay was developed to test the possibility 
that large side chains at position 68 inhibit binding between ScYpd1 and ScSln1-R1.  
Addition of ScSln1-R1 to labelled ScYpd1 mutants increased fluorescence intensity 
 
Figure 10. Phosphoryl transfer from phosopho~Ypd1 to Ssk1-R2 
Phosphoryl transfer from phosopho-ScYpd1 to Ssk1-R2. Phosphoryl transfer reactions contained 
equimolar concentrations of ScSln1-R1, ScYpd1, and ScSsk1-R2 proteins.   The autoradiographs 
were analyzed using ImageJ and the amount of radiolabel in ScSsk1-R2 bands in the presence of 
G68X mutants was quantified and compared with the amount of ScSsk1-R2 radiolabel in the 
presence of wild-type ScYpd1 band (set to 100%). 
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above baseline buffer dilutions, resulting in binding curves that appear to reach 
saturation at high concentrations (Figure 11).  
Dissociation constants (Kd) calculated from these binding curves for this panel 
of mutants ranged from 0.5 to 4 μM as shown in Table 4. The Kd for the ScSln1-R1 and 
ScYpd1-T12C interaction, 0.94 ± 0.38 μM, is in agreement with the Kd between 
ScSln1-R1 and wild-type ScYpd1 calculated from 
published kinetics data [44]. Though the Kd 
values observed for the mutants were within error 
of the wild-type protein, there was an observable 
trend that hydrophobic side chains decreased 
binding affinity and hydrophilic side chains increased affinity (Table 4).  
1.3.4 Crystal structure of ScYpd1-G68Q (Structure solution determined by Dr. 
Smita Menon.) 
 
Table 4. Binding constants for 
ScYpd1 with ScSln1-R1 
WT 0.94 ± 0.38 μM 
G68V 2.9 ± 0.08 μM 
G68L 1.3 ± 0.09 μM 
G68E 0.5 ± 0.13 μM 
G68Q 0.6 ± 0.27 μM 
Binding constants and standard deviations 
were derived from three replicates 
 
 
Figure 11. Representative titration of ScYpd1-T12C with ScSln1-R1   
ScYpd1-T12C~F (♦) and ScYpd1-T12C-G68Q~F (■) titrated with ScSln1-R1.  Curves were inverted 
and fitted to an expanded quadratic binding equation in order to calculate dissociation constants. 
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The ScYpd1-G68Q mutant was crystallized in space group P3121.  The structure 
was solved using molecular replacement to a resolution of 1.98 Å.  The model contains 
residues 2-167 with an average B-factor of 23.73 Å2.  Clear electron density is observed 
for the side chain of the glutamine substitution at position 68.  Few differences exist 
between this structure and the previously reported ScYpd1 crystal structures (PDB ID: 
1QSP) (Figure 13) [25, 27, 63].  
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The area around the site of 
phosphorylation is relatively unperturbed 
with an RMSD of 0.2 Å for all residues in 
αC and αD 1.4 Å. The highest deviation is 
seen in I18, which is displaced ~6.9 Å from 
its position in the wild-type structure 
(Figure 12).  In unit cell, the αA helix is 
located between αB (in contact with residues 
37-58) and αG (in contact with residues 130-
140).  The αA helix and the following turn (residues 10 – 27) show the largest shifts in 
 
Figure 13. Overlay and surface representations of wild-type ScYpd1 (cyan) 
(PDB ID: 1QSP) and the ScYpd1-G68Q mutant (magenta) 
A. The helices are numbered sequentially A to G from the N terminus to the C terminus with the 
four-helix bundle core composed of helices B, C, D and G. Phosphorylatable histidine and H+4 
glycine or glutamine are shown in stick representation. Movement of the αA helix is observed 
with a RMSD of 3.0 for this region.  
B. The volume of the H64 surface is shown in blue and the added bulk of the glutamine side chain 
is shown in yellow.    
 
 
Figure 12. Shift in I18 residue of 
ScYpd1-G68Q 
I18, which is displaced ~6.9 Å from its 
position in the wild-type structure.   
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Cα positions. The C RMSD between G68Q (10-27) and wild-type (10-27) is 3.0 Å. 
The movement of αA can be decomposed into two components.  The αA helix rotates 
approximately 30° upwards from its wild-type position centered on the N-terminal end 
of the helix (L9).  Secondly, the αA helix makes a ¼ rotation around its longitudinal 
axis (Figure 13).  Upon the αA twisting movement, the originally exposed I13 and I17 
are buried, E16 is shifted and L14 and I18 are now exposed. As a result, the alternative 
conformation of αA maintains hydrophobic interactions.  Minor shifts in the 
orientations of exposed side chains account for the remainder of the deviation between 
ScYpd1 structures.   
1.3.5 Mutations at the G68 position lead to changes in active site residues 
involved in catalysis (Molecular dynamics simulation performed by Clay 
Foster. Analysis of data completed in collaboration) 
 
To better understand the effects of mutating the H+4 residue in ScYpd1, 
mutations were modeled onto the existing ScSln1-R1/ScYpd1-BeF3
- structure (PDB ID: 
2R25). Short molecular dynamics runs were performed to allow the mutant active sites 
to relax.  This let us to observe the local structural changes caused by each substitution.  
The following G68 mutants were simulated, in addition to a wild-type control: S, V, E, 
L and Q.  Wild-type and G68S showed little structural perturbation upon relaxation, 
preserving the phosphoryl geometry and proper His-Asp alignment for phosphotransfer.  
G68V caused slight distortion of the phosphoryl geometry, but produced a significant 
shift in the β4α4 loop of ScSln1-R1, specifically at residue A1174.  G68E demonstrated 
moderate distortion, but an even more dramatic shift in β4α4 loop region.  In addition, 
the mutant glutamate formed direct interactions with ScSln1-R1 at both A1174 and the 
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highly conserved “switch” residue, T1173, which switches in orientation to form a new 
hydrogen bond upon RR activation. The positioning of the acidic side chain also 
appears to form a salt-bridge with K67 of ScYpd1. G68L led to severe distortion of the 
phosphoryl geometry, though the β4α4 loop of Sln1-R1 was unaffected. This distortion 
is most likely due to repulsive effects on the nearby ScSln1-R1 K1195, which is known 
to form a highly conserved salt-bridge with the phosphoryl group.  Finally, G68Q 
caused moderate active site distortion, but had a negligible effect on the β4α4 loop of 
ScSln1-R1. The added glutamine side chain was also able to satisfy several additional 
hydrogen bonds outside of the active site. 
1.4 Discussion 
HPt proteins play critical roles in signal transduction. Their primary role is to 
transfer a phosphoryl group from the receiver domain of a HHK to the receiver domain 
of an RR protein.  Deletion mutants of HPt proteins, resulting in the loss of signal 
transduction leads in decreased cell viability in both bacteria and yeast through 
suboptimal pathway regulation [11, 64-66]. The multi-domain protein ArcB (which 
consists of HK-RR-HPt domains) from E. coli transmits a signal to the terminal 
response regulator ArcA, mutants of residues in ArcBC, notably the H+4 residue G721, 
show a decrease in phosphotransfer ability [47]. When the H+4 residue of the P1 
domain from CheA (an HPt domain), G52, is mutated it has a highly detrimental effect 
on chemotaxis [46]. The ScYpd1-G68Q mutant from S. cerevisiae had a significantly 
diminished ability to both accept a phosphoryl group from the upstream ScSln1 and 
transfer it to the downstream ScSsk1 [45].  We aimed to investigate the role of this H+4 
residue in His-to-Asp multi-step phosphorelay systems.  
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In every currently known sequence containing an HPt domain, 98.4% of 
residues that occupy the H+4 position relative to the phospho-accepting histidine are 
small.  Glycine assumes this position in ~85% of cases, while ~12% contain a serine 
residue and ~2% are either proline or alanine.  This observation suggests that 
evolutionary preservation of a small residue was necessary for HPt domain function or 
interaction with binding partners. We hypothesized that substituting an amino acid with 
a bulky side chain at this position could potentially interfere with complex formation 
based off of a previous study which showed a diminished ability of accept a phosphoryl 
group and transfer the phosphoryl to a downstream binding partner [45].  
In this study, we used phosphotransfer assays, a fluorescence binding assay and 
X-ray crystallography to provide evidence that the S. cerevisiae HPt protein, ScYpd1, 
requires a small residue such as glycine in the H+4 position.  Without this small 
residue, phosphotransfer to its cognate response regulator, Ssk1, is inhibited. 
By creating a series of amino acid substitutions in the H+4 location, we 
determined that substitutions by smaller residues (S, A) at the H+4 position still 
allowed for phosphotransfer at near wild-type levels in ScYpd1. Mutations introducing 
larger side chain volumes (V, L, E) drastically inhibited phosphotransfer as both an 
acceptor and donor. The only exception was the G68Q substitution, where a large 
hydrophilic side chain still allowed for moderate phosphotransfer activity.  
To test if the functional defects observed for the S. cerevisiae ScYpd1-G68Q 
mutant were a result of loss of structural integrity, we used X-ray crystallography to 
solve the structure of the ScYpd1-G68Q mutant. We did not observe any broad overall 
structural changes, with the exception of movement of the AA helix and the significant 
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bulk at the interface’s surface. The intrinsic flexibility of αA suggests that the observed 
movement is likely due to crystal packing and not a static structural alteration; this helix 
is known to be the most flexible region in the HPt protein structure [41].  
In vitro fluorescence-based binding experiments between ScSln1-R1 and 
ScYpd1-G68X mutants showed no substantial changes in binding affinity as a 
consequence of the substitutions. These data demonstrate that the diminished 
phosphotransfer activity that we see in most of the larger mutants is not a consequence 
of changes in HPt:RR complex formation. Taken together, our results suggest the 
interface perturbations introduced by the non-functional mutants at position 68 are most 
likely negatively affecting the catalysis of the phosphotransfer reaction.  
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Our lab previously showed 
that there is a hydrophobic docking 
site on ScYpd1 for all three of its 
cognate binding partners. It consists 
of the αA, N-terminus of αB and C-
terminus of αC helices of ScYpd1 
[33].  From the crystal structures of 
ScSln1-R1 in complex with ScYpd1, 
we noted that the interfaces are 
highly complementary. The small 
volume of the active site cavity 
would not easily accommodate the 
addition of a bulky side chain 
without substantial rearrangement. If 
this additional bulk does not inhibit binding, as our fluorescence-based binding data 
confirms, then these rearrangements must be interfering with key residues involved in 
the phosphotransfer reaction. When the structures of ScYpd1-G68Q and ScYpd1 from 
the BeF3
- activated complex are aligned, the mutant glutamine side chain clashes with 
the highly conserved K1195 of ScSln1-R1 (Figure 14).  
K1195 has been implicated in the stabilization of the transition state formed 
during the His-Asp phosphotransfer event [67]. Any changes to its ability to neutralize 
the negatively charged transition state may have a significant effect on phosphotransfer 
between ScSln1-R1 and ScYpd1. 
 
Figure 14. Overlay of the ScYpd1-
G68Q mutant (magenta)(PDB ID: 
5JH4) with the ScYpd1•Sln1-
R1•Mg2+•BeF3- complex (cyan) (PDB 
ID: 2R25)   
The Q68 residue (magenta) of ScYpd1 occupies 
the same space as the K1195 residue (grey) of 
ScSln1-R1 (gray). Q68 and K1195 are shown in 
space filling representation.  Bound Mg2+ is colored 
green and BeF3- is shown in stick representation. 
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In addition to K1195, the molecular dynamics simulations we performed 
showed several other factors that may be affected by the substitutions. The geometry of 
the donor and acceptor atoms is critical for His-to-Asp phosphotransfer. Crystal 
structures of BeF3
- bound complexes, such as ScSln1-R1/ScYpd1 (PDB ID: 2R25) [26, 
27] suggest a conserved in-line orientation is necessary for nucleophilic attack and 
transfer between the residues. Correct geometry is maintained for HPts and their RRs by 
a narrow channel through which the histidine can access the aspartate. In the Sln1-
R1/Ypd1 complex, this is formed by adjacent residues on both proteins, including 
highly conserved positions such as Q1146, T1173, A1174 and K1195 on Sln1-R1, and 
K67, G68 and Q86 on ScYpd1. Any disruption to the arrangement of these residues 
would distort the in-line geometry. This is observed in the simulations of the larger 
substitutions (V, L, E, Q), with G68L causing the most severe phosphoryl distortion. 
The obvious explanation for this is the introduction of a large hydrophobic group into a 
mostly polar/charged active site. A related effect is shifting of β4α4 loop on ScSln1-R1. 
Upon phosphorylation, ScSln1-R1 undergoes a significant conformational change 
involving the β4α4 region. This allows for the transfer channel to form, and also for 
T1173 (side chain) and A1174 (main chain) to hydrogen bond with the oxygen atoms 
on either side of the tetrahedral phosphoryl group. In the case of Asp-to-His 
phosphotransfer, such as between the upstream ScSln1-R1 and ScYpd1, these 
interactions likely serve a similar purpose as K1195 in stabilizing the negatively 
charged pentavalent transition state. G68V and G68E both caused large shifts in this 
region, increasing the distance between A1174 and the phosphoryl oxygen. The G68Q 
substitution caused only moderate distortion, while leaving the β4α4 region largely 
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unaffected. This can explain why ScYpd1-G68Q was still able to function in 
phosphotransfer, albeit in a diminished capacity due to its moderate distortion. The 
additional hydrogen bonds satisfied by the glutamine side chain may also simply make 
it more favorable and/or stable than leucine or valine in the same environment. 
Interestingly, while both HPt and HK domains interact with receiver domains 
using phosphorylatable histidine residues, the strict H+4 conservation of HPt domains 
does not translate to HK domains.  In most HKs, a threonine or asparagine occupies the 
H+4 position in the conserved H-box motif of the DHp domain [68-70]. Comparison of 
HK:RR structures HK853:RR468 (PDB ID: EDGE) and ThkA:TrrA from Thermotoga 
maritima (PDB ID: 3A0R) with HPt:RR structures ScSln1-R1: ScYpd1 (PDB ID: 
10XB) and CheA-P1:CheY (PDB ID: 2LP4) demonstrates that the protein-protein 
interactions occur in different regions on the RR partner.  RR proteins interact with HK 
proteins using primarily the β3α3/β4α4 regions, but interact with HPt proteins using the 
β1α1/ β2α2/β3α3 regions.  An altered orientation allows for the larger residues found 
near the phosphorylatable histidine on most HKs. Large residues on the surface of the 
HPt in the H+4 location, as we have shown through radio-labeled phosphotransfer 
assays and molecular dynamic simulations, displace residues crucial for proper HPt: RR 
interactions due to their shifted binding orientations. Additional structural complexes of 
HK:RR cognate pairs as well as HPt:RR pairs would provide further insight.  
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Extended N-terminal region of the essential phosphorelay signaling 
protein Ypd1 from Cryptococcus neoformans contributes to structural 
stability, phospho-stability, and binding of calcium ions 
2.1 Introduction 
Histidine-to-aspartate (His-to-Asp) multi-step phosphorelay systems are used 
extensively by bacteria and lower eukaryotes to sense and respond to changes in their 
external environment and to regulate critical cellular functions such as progression 
through the cell cycle, mating, and the production of virulence factors [1-5]. While 
these signaling pathways are abundant in bacteria and lower eukaryotes, they are absent 
in humans and other higher eukaryotes making these promising targets for development 
of new antifungal therapeutics [6-9].  In bacteria, “two-component systems” generally 
consist of a single sensor histidine kinase (HK), and a response regulator protein (RR) 
[10-12]. In plants and fungi, this canonical two-component system has been expanded 
into as a multi-step phosphorelay system [13]. The HK is often replaced with a hybrid 
histidine kinase (HHK), which in addition to an HK domain includes a receiver domain 
typically found in RR proteins, a histidine phosphotransfer (HPt) protein, and multiple 
downstream RR proteins [14-16].   
The histidine phosphotransfer protein Ypd1, or a close homolog, is found at the 
branch point of multi-step His-to-Asp signal transduction pathways in several fungal 
organisms including Saccharomyces cerevisiae, Candida albicans, 
Schizosaccharomyces pombe, and Cryptococcus neoformans [17-19]. Ypd1 is often the 
sole HPt encoded by fungal organisms [20].  
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The hyperosmotic stress response pathway in S. cerevisiae has been extensively 
characterized [21, 22]. This pathway consists of a membrane bound HHK protein, 
ScSln1, the HPt protein, ScYpd1, and two RR proteins, ScSsk1 and ScSkn7. The 
ScSln1-ScYpd1-ScSsk1 branch of this pathway is responsible for regulation of the High 
Osmolarity Glycerol Pathway (HOG1) MAP kinase pathway that responds to external 
osmotic stress by production of the compatible osmolyte glycerol.  
The human fungal pathogen Cryptococcus neoformans (Cn) utilizes a 
homologous pathway to that found in S. cerevisiae (Figure 15), however, much less is 
understand about this pathway.
 
In S. cerevisiae only one HHK protein is encoded by the genome, while in C. 
neoformans, seven HHK proteins (CnTco1-7) are encoded. Only one of the proteins, 
 
Figure 15. Multi-step histidine-to-aspartate pathway in C. neoformans 
The multi-step histidine-to-aspartate pathway found in C. neoformans consists of at least two HHK 
proteins, CnTco1 and CnTco2, as well as an HPt protein, CnYpd1, and two RR proteins, CnSsk1 
and CnSkn7. 
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CnTco5, is predicted to contain transmembrane domains similar to ScSln1, while the 
remaining CnTco proteins are all predicted to be cytosolic [14]. CnTco1 and CnTco2, 
have been found to interact with CnYpd1 under osmotic stress conditions [19, 23].  
Disruption of CnTCO1 results in increased resistance to fludioxonil (an 
antifungal drug), and increased the production of melanin (a virulence factor) both of 
which are comparable phenotypes found when the CnHOG1 gene is disrupted [19]. 
Independent of Hog1 MAPK pathway activation, CnTCO1 also plays a role in sexual 
reproduction, and disruption of the gene results in defective cell-cell fusion during 
mating [19]. CnTco1 and CnTco2 have been found to play redundant roles in resistance 
to fludioxonil but have also been shown to have roles independent of each other. 
Disruption of the CnTCO1 gene but not the CnTCO2 gene results in attenuation of 
virulence, while disruption of the CnTCO2 gene results in sensitivity to hydrogen 
peroxide [19]. Another interesting characteristic of the CnTco1 and CnTco2 proteins are 
their unique domain architecture. CnTco1 is proposed to contain five HAMP domain 
repeats, while CnTco2 is proposed to contain repeating HK and RR domains (Figure 
16) [19]. The functions of the other CnTco proteins remain unknown.  
 
 
Figure 16. Proposed domain architecture of Tco1 and Tco2 HHK proteins 
found in C. neoformans  
Several CnTco proteins are proposed to have unique domain architecture. CnTco1 is proposed to 
contain five HAMP domain repeats, while CnTco2 is proposed to contain repeating HK and RR 
domains. 
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CnYpd1 is the sole HPt protein present in C. neoformans [24], and initial 
attempts at gene disruption were unsuccessful [19]. Severe growth defects were 
observed when CnYPD1 was not transcribed upon subsequent replacement of the 
CnYPD1 promotor with an inducible promoter, indicating that CnYPD1 is essential for 
viability [23]. CnYpd1 has been shown to be an intermediate in the regulation of the 
Hog1 MAPK pathway, as well as having roles that are independent of the Hog1 
pathway [23].  
C. neoformans also contains two response regulators homologous to the S. 
cerevisiae RR proteins found in the Sln1 Pathway, CnSsk1 and CnSkn7 [19]. CnSsk1 
has been implicated as being the major upstream regulator of the Hog1 MAPK pathway, 
with disruption of the CnSSK1 gene resulting in increased sensitivity to osmotic shock, 
UV irradiation, high temperature, and hydrogen peroxide, increased resistance to 
fludioxonil, enhanced mating, and increased virulence factor production of melanin and 
capsule [19]. The role of CnSkn7 is thought to be mainly independent of the Hog1 
pathway, with deletion of the CnSKN7 gene resulting in more severely attenuated 
virulence than CnHOG1 disruption mutants [19]. 
C. neoformans is ubiquitous to the environment and can be isolated from air and 
soil containing pigeon excrement.  Through serological studies it has been shown that 
up to 70% of children over the age of two living in urban areas such as the Bronx have 
been exposed to C. neoformans [25]. These infections very rarely progress to disease in 
individuals who are immunocompetent but there have been reported incidents [26].  
Fungal infections caused by C. neoformans are increasing at an alarming rate as 
the number of immunocompromised individuals (AIDS patients, organ transplant 
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recipients, and cancer patients) also increases. There are greater than 1 million 
cryptococcosis infections worldwide annually [27]. C. neoformans is the most common 
cause of fungal infections in HIV patients, reported to be annually responsible for over 
620,000 deaths within 3 months of infection in this population [28]. 
When C. neoformans causes symptomatic disease it often results in pneumonia-
like illnesses. The fungi can disseminate through the blood to the central nervous 
system to cause meningoencephalitis [29]. This most often occurs in individuals who 
are immunocompromised, including those with HIV/AIDS in underdeveloped countries 
such as Southeast Asia and Africa [30]. HIV infected patients who acquire 
Cryptococcus infections are at a very high risk of death, with as many as 60% of all 
diagnoses resulting in patient death [28]. There are four serotypes of C. neoformans: 
serotype A (var. grubii), serotype B and serotype C (var. gattii), and serotype D (var. 
neoformans). Serotype A is the most virulent, accounting for 95% of clinical isolates 
worldwide and 95% of isolates from AIDS patients [30]. 
Because C. neoformans has vast implications in human health, this work could 
result in the further help with the development of antifungal medications. The 
emergence of drug resistant strains of microorganisms has recently become more 
common, so there is a need for new medications to treat these infections. The most 
common drugs used in treating C. neoformans infections, Amphotericin B and 
Flucytosine, are highly toxic and often treatment with the drugs has to cease despite 
treatment being incomplete and fungal infection remaining [31].  The toxicity and the 
number of side effects that are associated with the current most common antifungal 
medications are extensive and with the requirement of long term use these medications 
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in the treatment in HIV/AIDs patients for cryptococcosis fungal infections, this has 
become increasingly problematic [32]. Because the His-to-Asp signal transduction 
pathways found in pathogenic fungi like C. neoformans are not found in humans or 
other higher eukaryotes, and protein components such as CnYpd1 have been shown to 
be associated with virulence and are essential for viability, His-to-Asp pathway proteins 
are excellent targets for the development of new antifungal medications.  
Here I report my work on the biochemical characterization of the predicted 
histidine phosphotransfer protein Ypd1 from the fungal human pathogen C. 
neoformans.  Results from this study indicate that the extended N-terminal amino acid 
sequence confers structural stability, contributes to the phosphorylated life-time of the 
protein, and provides binding sites for calcium ions.  Results from our studies will 
contribute to a better understanding of how HPt proteins mediate multi-step 
phosphorelay signaling pathways in pathogenic fungi. 
2.2 Material and Methods 
2.2.1 Materials 
 
All chemicals for protein expression and purification were of ultrapure grade 
from Ameresco® or Sigma®. The pTrcHis-TOPO® TA Expression Kit was purchased 
from Invitrogen for gene cloning. Ni-NTA affinity resin was purchased from McLab 
(NiNTA). HiTrapQ columns were purchased from GE Healthcare and were used on an 
AKTÄ prime chromatography system from GE Healthcare. [γ-32P] ATP (3000 
Ci/mmol) was purchased from Perkin Elmer. TEV protease was produced in our 
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laboratory from an expression plasmid that was kindly given to us by J. Doudna at 




All constructs used in this study were confirmed by DNA sequencing at the 
Oklahoma Medical Research Foundation DNA Sequencing Facility. The CnYPD1 gene 
was PCR amplified from cDNA (kindly 
provided by Dr. Jan Fassler, University of 
Iowa), into a pTrcHis-TOPO vector (Figure 
17) using the pTrcHis TOPO® TA 
Expression Kit (Life Technologies) to 
construct the plasmid pTrcHis-CnYPD1. 
The primers 768/769 in Table 12 in 
Appendix A were used for the PCR reaction. The PCR program used was 95°C for 30 
seconds, 65°C for 1 minute, 72°C for 1 minute, repeated for 20 cycles, and 72°C for 5 
minutes. After transformation into E. coli DH5α cells and overnight culture, plasmid 
DNA was isolated using the QIAprep Spin Miniprep Kit (Qiagen). 
Site-directed mutagenesis PCR was used to remove the enterokinase (EK) site 
present in the pTrcHis-TOPO vector and replace it with a TEV protease cleavage site 
for higher cleavage specificity. Primers 809/810 listed in Table 12 in Appendix were 
used for PCR reaction. The resulting plasmid was called TrcHis-CnYPD1-TEV. For the 
PCR reaction for replacement of the EK site the programmed method was 95°C for 30 
 
Figure 17. Plasmid map of 
pTrcHis-TOPO vector 
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seconds, five cycles of 95°C for 30 seconds, 52°C for 1 minute, 72°C for 7 minutes, 
followed by thirteen cycles of 95°C for 30 seconds, 55°C for 1 minute, and 72°C for 7 
minutes.  DpnI (10 U) was used to digest methylated parental DNA while retaining the 
newly synthesized DNA. 
The pTrcHis-CnYPD1 plasmid served as a template for making a series of N-
terminal truncation constructs (Δ5, Δ19, Δ43, Δ50, Δ60, Δ77, Δ83, and Δ100) using 
primers listed in Table 12 in Appendix A. For the PCR reaction, the denaturation 
temperature was set to 95°C for 1 minute, the annealing temperature was set to 55°C for 
1 minute, and the extension temperature was set to 72°C for 7 minutes for 20 cycles.  
The hypothetical phospho-accepting histidine residue of CnYpd1, H138, was 
mutated to a glutamine residue by site-directed mutagenesis PCR in both the pTrcHis-
CnYPD1 and pTrcHis-CnYPD1-TEV plasmids to create the pTrcHis-CnYPD1-H138Q 
and pTrcHis-CnYPD1-H138Q-TEV plasmids. For the PCR reaction, the denaturation 
temperature was set to 95°C for 1 minute, the annealing temperature was set to 55°C for 
1 minute, and the extension temperature was set to 72°C for 7 minutes for 12 cycles 
with primers 721/722 listed in Table 12 in Appendix A. DpnI (10 U) was used to 
digest methylated parental DNA while retaining the newly synthesized DNA. 
Three mutants were constructed using pTrcHis-CnYPD1 as a template in order 
to determine which specific residues are involved in metal ion binding, E48A-E54A, 
E58A and D60A-E67A.  CnYpd1-E58A was cloned using site-directed mutagenesis 
PCR with the same PCR program used to create the pTrcHis-CnYPD1-H138Q mutant. 
E48A-E54A and D60A-E67A were cloned using ligation independent cloning [34]. 
Primers used are listed in Table 12 of Appendix A. 
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The receiver domain (nucleotides 3022-3780) of CnSSK1 from C. neoformans 
strain H99 (CnSsk1-R2) was PCR amplified from cDNA into a pET-21a vector by Dr. 
Katie Branscum using oligo pairs 711/712 found in Table 12 of Appendix A.  
The receiver domain of CnSKN7 (nucleotides 2062-3159) from C. neoformans 
strain H99 (CnSkn7-R3) were amplified from cDNA using oligo pairs 711/712 found in 
Table 12 of Appendix A and into the TrcHis-Topo vector by Brittany Kitchens.  
 
2.2.3 Protein expression and purification 
 
All plasmids were transformed into Escherichia coli DH5α cells for protein 
expression. Protein purification and growth conditions was consistent for all constructs. 
Ten mL overnight cultures were used to inoculate 1 L of Luria Broth (LB). Protein 
expression was induced with 0.4 M isopropyl β-D-1-thiogalactopyranoside (IPTG) 
(Gold Biotechnology) when at OD600 reached 0.5. Cells were grown at 37°C and 
harvested at approximately 10 hours. The cells were pelleted by centrifugation at 5000 g 
and then suspended in lysis buffer (20 mM Bis-tris pH 6.5, 500 mM NaCl, and 20 mM 
imidazole). Cells were lysed using sonication and the supernatant was clarified by 
centrifugation at 17000 g. The clarified supernatant was applied to a 5 mL Ni-NTA 
agarose column and protein was eluted from the column using elution buffer (20 mM 
Bis-tris pH 6.5, 50 mM NaCl, and 300 mM imidazole).  Elution fractions containing the 
Ypd1 protein were applied to a 5 mL HiTrap Q anion exchange column (GE Life 
Sciences) using an AKTÄ Prime chromatography system.   
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CnYpd1 eluted from the Q column at approximately 300 mM NaCl. CnYpd1 
containing fractions were combined and concentrated to approximate 500 μL using a 
Amicon Ultra-15 centrifugation unit with a 10 kDa molecular weight cutoff (Millipore) 
and loaded onto a Superdex 200-Increase column (GE Life Sciences) equilibrated in 50 
mM Tris-HCl pH 8.0 and 150 mM NaCl using an AKTÄ Pure M1 system in the Protein 
Production Core at the 
University of Oklahoma. 
Fractions containing pure 
CnYpd1 proteins were pooled 
and protein concentration was 
determined by absorbance at 280 
nm using a calculated extinction 
coefficient for each CnYpd1 
construct (Table 5). Protein 
appears to be approximately 
95% pure and yield was approximately 40 mg/L of cell culture. 
CnSsk1-R2 (~29 kDa) and CnSkn7-R3 (~40 kDa) were expressed in BL21 
(DE3) Rosetta cells and DH5α cells respectively. Cells were grown at 16°C for 
approximately 18 hours. Cells were lysed by French Press in lysis buffer (20 mM Na/K 
Phosphate pH 7.4, 500 mM NaCl, 10 mM Imidazole). Supernatant was passed over a 5 
mL Ni-NTA column, column was washed with wash buffer (Na/K Phosphate pH 7.4, 
500 mM NaCl, 30 mM Imidazole). Proteins were eluted from column with 400 mM 
imidazole. Protein containing fractions were pooled and buffer exchanged into a buffer 
Table 5. Calculated molecular weight, 













CnYpd1tag 27586 18575 4.46 
CnYpd1notag 23449 17085 4.33 
CnYpd1 ΔN5 27115 16960 4.35 
CnYpd1 ΔN15 26175 18575 4.46 
CnYpd1 ΔN19 25773 18575 4.46 
CnYpd1 ΔN43 22970 18575 4.40 
CnYpd1 ΔN50 22254 18450 4.40 
CnYpd1 ΔN60 21226 18575 4.47 
CnYpd1 ΔN70 20065 18575 4.73 
CnYpd1 ΔN 77 15184 18450 4.88 
CnYpd1ΔN84 18443 18575 4.94 
CnYpd1ΔN100 16393 18450 5.96 
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containing 20 mM Na/K Phosphate pH 7.4, 50 mM NaCl for anion exchange 
chromatography. Protein containing fractions were concentrated using an Amicon 
centrifugation unit with a 10 kDa molecular weight cut off. Pure proteins were aliquoted 
and stored at -20°C in the presence of 10% glycerol.  
The S. cerevisiae phosphorelay proteins, histidine kinase and receiver domains 
from ScSln1 (ScSln1-HKR1), and receiver domain from ScSsk1 (ScSsk1-R2), were 
purified following methods described previously in our laboratory [35, 36]. 
2.2.4 Determination of oligomeric state of CnYpd1 
 
Size exclusion chromatograph, size exclusion chromatography with multi-angle 
light scattering analysis and native gel analysis were performed on CnYpd1 protein 
samples in order to determine the oligomeric state of the protein in solution. CnYpd1 
was purifies as previously described and subjected to SEC on a calibrated S200 column 
in the Protein Production Core at the University of Oklahoma. S. cerevisiae ScYpd1 
was purified according to previously published protocols [37]. SEC was repeated on a 
protein sample containing both ScYpd1 and CnYpd1 in a 20 mM Tris pH 8.0, 50 mM 
NaCl buffer. Similarly, SEC was performed on a series of protein constructs (ScYpd1, 
CnYpd1, CnYpd1 ΔN50, CnYpd1 ΔN60, and CnYpd1 ΔN70) on a calibrated Superdex 
200 Increase column in a 50 mM Tris pH 7.0, 150 mM NaCl buffer.  
To determine if cysteine residues were involved in the elution volume of the 
protein, SEC was performed on CnYpd1 samples in the presence and absence of 1mM 
βME. 
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Native gel analysis was performed on CnYpd1 protein samples.  Protein was 
purified in a buffer containing 20 mM Tris pH 8.0 and 150 mM NaCl.  Additives were 
added to protein samples and protein was separated on a 15% native gel.  
Size exclusion chromatography with multi-angle light scattering analysis (SEC-
MALS) was performed on CnYpd1 protein samples from anion exchange fractions. 
Protein was buffer exchanged into a 50 mM Tris pH 8.0, 150 mM NaCl buffer and 
SEC-MALS was performed.  
2.2.5 Pull down assay with receiver domain of CnSkn7 (CnSkn7-R3) 
 
Pure CnSkn7-R3 protein was bound to a 5 mL Ni-NTA column and unbound 
protein was washed from the column with wash buffer (50 mM Tris pH 8.0 and 150 
mM NaCl). Pure CnYpd1 protein was then passed over the column. The column was 
again washed with wash buffer. Proteins were then eluted from the column with wash 
buffer containing 300 mM imidazole. Aliquots were taken of each step and were 
separated on a 15% SDS-PAGE gel.  
2.2.6 Solubility studies of CnYpd1 N-terminal deletion constructs 
 
E. coli cells expressing various constructs of CnYpd1 were grown in 500 mL 
cultures at 37°C for 6 hours.  Samples were taken prior and subsequent to induction 
with IPTG, and of the clarified supernatant and pellet fractions subsequent to 
sonication. The percentage of CnYpd1 distributed in the supernatant versus pellet 
fractions were estimated using ImageJ software [38]. 
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2.2.7 In vitro phosphorylation assay  
 
To test the ability of CnYpd1 to function as an HPt protein, the HK and RR 
domains of the S. cerevisiae HHK Sln1 were used as a phosphoryl donor. GST-tagged 
ScSln1-HKR1 was purified and left bound to glutathione–sepharose 4B resin 
(Amersham Pharmacia Biotech AB) as described previously ([39]). 
Autophosphorylation of the bead-bound GST-Sln1-HKR1 protein using γ-32P-ATP 
(Perkin Elmer) was performed according to previously published protocols from our 
laboratory [40]. Phospho~GST-ScSln1-HKR1 (GST-ScSln1-HKR1~P) was then added 
to tubes containing an equal molar amount of an HPt protein alone, or HPt protein with 
a RR receiver domain (ScSsk1-R2),  aliquots were obtained and the reaction was 
quenched with stop buffer (250 mM Tris, pH 6.8, 40% glycerol, 8% sodium dodecyl 
sulfate (SDS), 50 mM EDTA. All CnYpd1 constructs were phosphorylated in this 
manner. For visualization of the reaction, samples were applied to a 15% SDS 
polyacrylamide gel and electrophoresed at 200 V for 45 min. The SDS gels were 
wrapped in plastic wrap and exposed to a phosphorimager screen. The radioactivity of 
each band was quantified using a Typhoon phosphorimager (Molecular Dynamics). 
For phosphorylated life-time studies, CnYpd1 or a CnYpd1 N-terminal deletion 
mutant, was incubated with Bead-bound GST-ScSln1-HKR1~P for 10 minutes.  After 
the 10 minute incubation, GST-tagged ScSln1-HKR1 was removed from the reaction by 
gentle centrifugation (Figure 18).  The supernatant containing only phospho~HPt 
protein was placed into a separate Eppendorf tube, aliquots were removed at specific 
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time points and the reaction was quenched with stop buffer.
 
2.2.8 Size exclusion chromatography analysis for metal binding studies 
 
Pure CnYpd1 protein was buffer exchanged into a buffer containing either 20 
mM Sodium Citrate pH 5, 50 mM NaCl, and 1 mM EDTA or 20 mM Tris pH 8, 50 mM 
NaCl, and 1 mM EDTA using an Amicon Ultra-15 Centrifugation Unit with a 10 kDa 
molecular weight cutoff.  All buffers were passed over a 10 mL Chelex® column to 
remove trace metal ions. Proteins were subjected to size exclusion chromatography on a 
Superdex 200 Increase column using an AKTÄ Pure M1 system equilibrated with the 
corresponding buffer in the Protein Production Core Facility at the University of 
Oklahoma. Fractions containing CnYpd1 protein were pooled and buffer exchanged 
into the corresponding buffer without EDTA.  Protein was then split into four equal 
parts. Metal ions were re-introduced to the solution by the addition of 10mM MgCl2, 10 
 
Figure 18. Schematic for phosphorylation of CnYpd1 
Heterologous donor ScSln1-HKR1 was used to phosphorylate CnYpd1 and removed from 
reaction by gentle centrifugation.  
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mM MnCl2, 10 mM CaCl2, or 10 mM CoCl2 to the split protein fraction. Proteins were 
incubated in the presence of the metal ion for 3 hours. Protein samples were then loaded 
onto the Superdex 200 Increase column equilibrated in the corresponding buffer. 
Fractions containing the CnYpd1 protein were collected and analyzed by SDS-PAGE 
analysis.  
2.2.9 Inductively coupled plasma atomic emission spectroscopy (ICP-MS) 
analysis 
 
 Inductively coupled plasma mass spectrometry (ICP-MS) analysis was 
performed on CnYpd1 to determine whether metal ions were bound to the native 
protein and, if so, the molar concentration. All purification buffers were passed through 
a column of Chelex® resin to remove trace metal ions. Chelex® treated water was used 
to rinse all glassware and centricon concentration units.  Protein was concentrated to 
approximately 50 mg/mL and sent overnight on dry ice to Dr. Martina Ralle at the 
Elemental Analysis Core at Oregon Health and Science University where ICP-MS was 
performed. Protein samples were analyzed for magnesium, cobalt, calcium, copper, 
nickel and zinc ions. A second analysis was performed on a separate purification of 
CnYpd1, CnYpd1 ΔN50, and CnYpd1 ΔN70 with protein concentrations of 
approximately 1 mg/mL, metal ion concentration was only determined for calcium. To 
examine possible metal binding sites, CnYpd1 E58A, E48A-E54A and D60A-E67A 
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2.3 Results  
2.3.1 CnYpd1 functions as a histidine phosphotransfer protein 
 
CnYpd1 was purified to approximately 95% purity (Figure 19) and when 
necessary the affinity tag used during protein purification was cleaved using TEV 
protease.  
 
HPt proteins or domains range in size from approximately 150 to 300 amino 
acids, they often have low sequence homology except in the region surrounding the 
conserved phospho-accepting histidine, which is more highly conserved [41]. Currently, 
only one HPt protein has been identified in C. neoformans, CnYpd1 [19].  While 
CnYpd1 is expected to be homologous in structure and function to ScYpd1, amino acid 
sequence identity between the two proteins is only about 29%. An extension at the N-
terminal region of CnYpd1 accounts for the difference in sizes between CnYpd1 and 
 
Figure 19. Purification summary for CnYpd1 
15% coomassie stained SDS-PAGE gels showing the protein purification summary of CnYpd1 and 
TEV cleavage. CnYpd1 protein indicated by red arrow.  
A. Lane 1: Supernatant after cell lysis, Lane 2: Pellet after cell lysis, Lane 3: Elution from Ni-
NTA column, Lane 4: Pooled fractions from HiTrap Q anion exchange chromatography, 
Lane 5: Pooled fractions from size exclusion chromatography.  
B. Lane 1: Pooled fractions from SEC prior to cleavage with TEV protease, Lane 2: Subsequent 
to overnight cleavage, Lane 3 and 4: Flow through from Ni-NTA column wash containing 
CnYpd1.  
 
 70   
 
ScYpd1 (209 and 167 amino acids, respectively) as shown in Figure 20. This extended 
N-terminal region shares no close sequence homology with any other protein domains, 
including other HPt proteins with extended N-terminal regions such as Mpr1 from 
Schizzosaccharomyces pombe and Wallemia ichthyophaga, or AHP2 from Arabidopsis 
thaliana (Figure 20).  
 
 
Figure 20. Representative sequence alignment of HPt proteins 
Amino acid sequences of HPt proteins were aligned using ClustalX 2.1 and visualized using Jalview 
2.8.2.  Highly conserved residues are shaded dark blue, while less conserved residues are shaded in 
lighter blue. The phospho-accepting histidine residue is denoted by a red asterisk (*). Secondary 
structure of the known crystal structure of Ypd1 from S. cerevisiae (PDB ID: 1QSP) is diagrammed 
above the alignment. 
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 Cloning of full-length genes and protein expression proved to be difficult, in our 
hands, for the two upstream HHK proteins in C. neoformans, CnTco1 and CnTco2, and 
the two downstream RR proteins, CnSsk1 and CnSkn7 that are known to interact with 
CnYpd1 [19]. These HHK and RR proteins are very large multi-domain proteins of 
greater than 1000 residues.  When further attempts to isolate individual domains of 
each of these proteins were made, the protein products were found to be highly 
insoluble or have very low yields during expression in E. coli. Because of these 
difficulties, a heterologous system using purified HHK ScSln1 and RR ScSsk1 proteins 
from S. cerevisiae were used instead to characterize biochemical properties of CnYpd1 
in vitro. 
 CnYpd1 is able to function in vitro as a HPt protein by accepting phosphoryl 
groups from the heterologous upstream donor ScSln1 from S. cerevisiae (ScSln1-
HKR1), as well as transferring phosphoryl groups to a downstream RR protein ScSsk1 
(ScSsk1-R2) (Figure 21). Radiolabeled phosphoryl groups from phospho~GST-
ScSln1-HKR1 were shown to be almost completely transferred to CnYpd1 within 1 
minute of incubation.  Based on a sequence alignment of HPt proteins, residue H138 
was predicted to be the site of phosphorylation.  When H138 was mutated to a 
glutamine (H138Q), the ability of CnYpd1 to accept phosphoryl groups was completely 
abolished, confirming that H138 is the site of phosphorylation.  
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2.3.2 CnYpd1 interactions with downstream RR proteins 
 
C. neoformans encodes two RR proteins which interact with CnYpd1, CnSsk1 
and CnSkn7. These proteins are very large multi-domain proteins, both are composed of 
over 1000 amino acids. Initial attempts at cloning full length genes from cDNA were 
unsuccessful, possibly because of low DNA concentration or sheering of mRNA during 
isolation, the focus was predominantly on isolating receiver domains which interact 
with CnYpd1.  Extensive attempts by Dr. Katie Branscum to expression and purify 
CnSsk1 failed to result in protein that was available for assay.  Information on 
constructs and protein expression/purification can be found in her dissertation [42]. 
 
Figure 21. Phosphorylation of CnYpd1 from a heterologous phosphodonor 
The HK and RR domains from a heterologous donor, Sln1 from S. cerevisiae (Sln1-HKR1), were 
used to phosphorylate CnYpd1. ScSln1-HKR1 was autophosphorylated using 0.1 μM γ-32P-
labeled ATP (lane 1).  ScSln1-HKR1 was incubated with CnYpd1 alone (Lane 2) or with ScSsk1-
R2 (lane 3), CnYpd1-H138Q alone (lane 4) or with ScSsk1-R2 (lane 5).  
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Attempts by myself to alter expression and buffer conditions also did not improve 
protein yield/activity. Full length protein may be necessary for complete solubility and 
function.  
 Initial cloning and expression of the receiver domains of CnSkn7 (CnSkn7-R3) 
were performed by Brittany Kitchens, Jamie Sykes performed initial expression and 
protein purification experiments.  Yield was very low due to both low expression and 
poor solubility. I attempted to improve expression and solubility by altering expression 
strains and conditions as well as buffer conditions for purification. Expression at low 
temperatures in E. coli DH5α cells (generally only used for cloning) appeared to 
slightly improve expression as did use of high concentrations of NaCl during lysis. A 
large percentage of the protein was still found to be insoluble and yield was very low 
(Figure 22).
 A pull down experiment was performed to test if CnYpd1 and CnSkn7-R3 are 
able to interact in vitro. Both CnSkn7-R3 and CnYpd1 are purified using affinity 
chromatography with 6X-HIS tags. The affinity tag for CnYpd1was removed using 
 
Figure 22. Expression and purification of CnSkn7-R3 
15% coomassie stained SDS-PAGE gel showing the protein purification of CnSkn7-R3.  Lane 1: 
Whole cell prior to lysis, Lane 2: Supernatant after cell lysis, Lane 3: Pellet after cell lysis, Lane 4: 
Wash with 10 mM imidazole, Lane 5: Wash with 50 mM imidazole Lane 6: Wash with 100 mM 
imidazole, Lane 7: Elution with 250 mM imidazole, Lane 8: Elution with 400 mM imidazole. 
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TEV protease. Results indicate that CnYpd1 and CnSkn7-R3 can form a stable 
interaction (Figure 23A). Some CnYpd1 was present in the wash, indicating that not all 
CnYpd1 bound to CnSkn7-R3.  Preliminary results also show that CnYpd1 is also able 
to pass a phosphoryl group to CnSkn7-R3. The transfer from CnYpd1 to CnSkn7 was 
observed to be very weak, however, and appeared to take a relatively long amount of 
for the transfer to occur (Figure 23B). It is possible that an alternate construct of 
CnSkn7 may yield better results. 
 
2.3.3 N-terminal region of CnYpd1 important for structural integrity 
 
 A series of N-terminal deletion mutants were created and analyzed with respect 
to protein folding/stability, phosphotransfer activity, phospho-stability and ability to 
bind metal ions. N-terminal deletion mutants were created using secondary structure 
predictions from PSIPRED [43] (Figure 24).  
 
Figure 23. Pull down assay and phosphotransfer between CnYpd1 and 
CnSkn7-R3 
A. CnSkn7-R3 was bound to a 5 mL Ni-NTA column. Unbound protein was washed from the 
column.  CnYpd1 was passed over the column and unbound CnYpd1 was removed by washing 
with wash buffer (150 mM Tris pH 8.0, 150 mM NaCl). The proteins were then eluted from the 
column with wash buffer containing 300 mM imidazole. Samples were taken at each step and 
separated on a 15% SDS-PAGE gel. Lane 1: CnSkn7-R3 flow through, Lane 2. CnSkn7-R3 
wash, Lane 3: Resin containing CnSkn7-R3, Lane 4: CnYpd1 flow through, Lane 5: CnYpd1 
wash, Lane 6: Resin containing both CnYpd1 and CnSkn7-R3, Lane 7: Elution, Lane 8: Resin 
after elution. 
B. Phosphotransfer from Phospho~CnYpd1 to Skn7. Aliquots were taken at 15 and 75 minutes and 
separated on a 12% SDS-PAGE gel. 
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Whole-cell, supernatant, and pellet samples after lysis were analyzed for each 
N-terminal deletion mutant (Figure 25). 
 
Figure 24. CnYpd1 N-terminal deletion mutants  
Secondary structure predictions were performed using PSIPRED. Deletion mutants were created 
based on position of helices and region predicted to be an HPt domain. 
 
 




Full length CnYpd1, CnYpd1 ΔN5, ΔN19, and ΔN43 were found to be 
completely soluble with approximately 100% of the protein found in the supernatant. 
 
Figure 25. Solubility studies of CnYpd1 deletion constructs 
Comparison of amount of protein for each CnYpd1 deletion construct found soluble in 
supernatant and/or insoluble in pellet after cell lysis.  
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CnYpd1 ΔN50, ΔN60, and ΔN70 were all 
found to be approximately 50% soluble. 
CnYpd1 ΔN77, ΔN83, and ΔN100 were 
found to be completely insoluble (Table 
6).  
All soluble N-terminal deletion 
mutants were able to accept phosphoryl 
groups to the same extent as wild-type 
CnYpd1 (Figure 26). 
 
These results indicate that while the first 40 residues are dispensable for protein 
folding/solubility, subsequent removal of residues causes the protein to become 
increasingly insoluble. Secondary structure predictions using PSIPRED [43] indicates 
 
Figure 26. Phosphorylation of CnYpd1 ΔN constructs  
CnYpd1, CnYpd1 ΔN15, ΔN50, ΔN60, and ΔN70 were incubated with phospho~GST-ScSln1-
HKR1. GST-ScSln1-HKR1 was removed from the reaction after a 5 minute incubation. Aliquots were 
removed of only CnYpd1 construct and mixed with stop buffer to quench the reaction. 
Table 6. Approximate percentage 
of CnYpd1 ΔN protein found in 









CnYpd1 100 0 
CnYpd1 Δ5 100 0 
CnYpd1 Δ19 100 0 
CnYpd1 Δ43 100 0 
CnYpd1 Δ50 50 50 
CnYpd1 Δ60 60 40 
CnYpd1 Δ70 50 50 
CnYpd1 Δ77 10 90 
CnYpd1 Δ84 0 100 
CnYpd1 Δ100 0 100 
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that residues 75-85 may form an -helix that would correspond to the αA helix found in 
other HPt proteins (Figure 24). Our solubility studies indicate that this helix may be 
important for protein stabilization and solubility. Structural information available for S. 
cerevisiae Ypd1 (PDB ID: 1QSP) and A. thaliana AHP2 (PDB ID: 4PAC) show that 
this helix has amphipathic character and forms a “cap” covering a larger hydrophobic 
patch composed of the core helices of the four α-helix bundle, suggesting that it is 
important for structural stabilization and proper alignment of these helices as well as 
protection from solvent.  
2.3.4 CnYpd1 functions a monomer in solution 
 
 To determine the oligomeric state of CnYpd1, size exclusion chromatography 
was performed on a calibrated Superdex 200 (S200) column in the Protein Production 
Core at the University of Oklahoma. The predicted molecular weight of CnYpd1 is 
expected to be approximately 28 kDa, however, the protein eluted from a calibrated 
S200 size exclusion column at the same elution volume as a globular protein with a 
molecular weight of approximate 70 kDa (Figure 27).  There is no indication of a lower 
molecular weight peak eluting from the column, indicating that the protein is in a single 
form. 
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 This apparent molecular weight may be a result of CnYpd1 being a dimer or 
non-globular in shape as the result of the addition N-terminal amino acid sequence. The 
crystal structure of the Ypd1 protein from S. cerevisiae (ScYpd1) shows a monomeric 
 
Figure 27. CnYpd1 apparent molecular weight on a calibrate S00 column 
CnYpd1 elutes on a calibrated S200 column as a protein with an apparent molecular 
weight of approximately 75 kDa.  
 
 
Figure 28. SDS-PAGE gel of CnYpd1 protein 
Aliquots obtained from fractions collected from SEC performed on CnYpd1 protein 
to determine oligomeric state. 
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protein that is oblong in shape rather than 
globular (PDB ID: 1QSP).  SEC was 
performed on a protein sample containing 
both ScYpd1 and CnYpd1 in a 20 mM Tris 
pH 8.0, 150 mM NaCl buffer (Figure 29).  
 ScYpd1 has a calculated molecular 
weight of ~20 kDa and elutes from the S200 
Increase column with an apparent molecular 
of ~30kDa, showing a protein of 1.5 times 
the predicted molecular weight. CnYpd1 with 
a calculated molecular weight of ~28 kDa eluted from the column with an apparent 
molecular weight of ~63 kDa, 2.2 times the predicted molecular weight (Table 7). 
 
ScYpd1 does not behave in an “ideal” manner on the SEC column, most likely due to 
its oblong shape.  This results in an apparent Stokes radius that is larger than is 
predicted for the monomeric protein. Results of a ratio of apparent molecular weight to 
predicted molecular weight using SEC alone would not indicate monomeric or dimeric 
state of ScYpd1.  Consequently, a ratio of an apparently vs. predicted molecular weight 













ScYpd1 16.2 19.7 30.0 1.5 
CnYpd1 14.1 27.6 62.9 2.3 
 
 
Figure 29. Elution profile of 
ScYpd1 with CnYpd1 on a S200 
column 
SEC was performed on a combined 
sample of ScYpd1 and CnYpd1 in a 
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of 2.3 for CnYpd1 appears to indicate that CnYpd1 is a dimer in solution, but is not 
completely rule out an irregularly shaped oblong protein.  
 If CnYpd1 behaves as a dimer, the most likely dimerization interface location 
should be in the N-terminal region.  It is crucial for the phospho-accepting histidine 
residue to remain solvent exposed, so it is unlikely that the C-terminal HPt domain 
would be a dimerization interface. Full length CnYpd1, N-terminal deletion mutants of 
CnYpd1 and ScYpd1 were all subjected to SEC on a S200 increase column equilibrated 
in a 50 mM Tris pH 7.0, 150 mM NaCl buffer (Table 8).  
 
Table 8. Predicted and apparent molecular weights of ScYpd1, full length 













ScYpd1 16.2 19.8 30 1.5 
CnYpd1 FL 14.1 27.6 74 2.7 
CnYpd1 ΔN50 15.5 22.2 42 1.9 
CnYpd1 ΔN60 16.1 21.2 31 1.5 
CnYpd1 ΔN70 16.2 20.0 30 1.5 
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Complete remove of the N-terminal region 
(CnYpd1 ΔN70) results in a protein that 
appears to elute from the SEC S200 column 
in a similar manner to ScYpd1, a known 
monomer. Conversely, full length CnYpd1 
has an apparent to predicted molecular 
weight ratio of 2.7. These results may 
indicate that CnYpd1 functions as a dimer in 
solution taking into account the oblong 
shape and addition N-terminal region which 
may form a small domain which acts as a 
dimerization domain.  
 CnYpd1 contains 2 cysteine residues, C96 and C130. In order to eliminate the 
possible that these residues were involved in potential dimerization SEC was performed 
on protein samples in the presence and absence of reducing agent (1 mM β-
mercaptoethanol (BME)). Results show no change in elution profile with the addition of 
reducing agent, indicating that cysteine residues are not involved with potential 
dimerization (Figure 30).  
 If CnYpd1 ΔN70 and ScYpd1 behave in a similar manner during SEC the N-
terminal region must be responsible for causing either dimerization or a drastic shape 
change from ScYpd1. If CnYpd1 is a dimer in solution, there should be a way to break 
apart dimer into monomers.  It is also possible that, depending on how much of the 
potential dimerization region is removed, heterodimers may form between different 
 
Figure 30. SEC elution profile of 
CnYpd1 in presence and absence 
of reducing agent 
SEC was performed on CnYpd1 protein 
samples in the absence or addition of 1 mM 
BME. Protein was incubated with BME for 
1 hour before SEC was performed.  
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CnYpd1 protein constructs. Native gel assays were performed using CnYpd1, CnYpd1 
ΔN50 and CnYpd1 ΔN 70.  
 
 Results from the native gel analysis indicate no evidence of a “monomer” 
present in in the presence of an increasing concentration of NaCl , high concentrations 
of different chaotropic salts such as sodium or potassium thiocyanate, high percentages 
of detergent, or high concentrations of EDTA (Figure 31). There was also no evidence 
of hetero-dimer formation between full length CnYpd1 and either CnYpd1 ΔN50 or 
CnYpd1 ΔN70. From SEC experiments there is no evidence of second peak at lower 
MW during chromatography.  
 
Figure 31. Native gel analysis of CnYpd1 constructs 
Pure CnYpd1, CnYpd1 ΔN50 and CnYpd1 ΔN 70 were subjected to native gel analysis. Protein 
was in buffer containing 50 mM Tris pH 8.0 and 150 mM NaCl, Each addition component was 
added to protein sample and incubated for 15 minutes before being separated on a 15% Native gel.  
A. Lane 1: CnYpd1, Lane 2: 5% Trixton-X, Lane 3: 250 mM NaCl, Lane 4: 500 mM NaCl, 
Lane 5: 750 mM NaCl, Lane 6: 1 M NaCl, Lane 7:2 M NaCl 
B. Red boxes indicate CnYpd1, yellow boxes indicate CnYpd1 ΔN50, and purple boxes 
indicate CnYpd1 ΔN70. Lane1: CnYpd1, Lane 2: CnYpd1 ΔN50, Lane 3: CnYpd1 + 
CnYpd1 ΔN50, Lane 4: CnYpd1 ΔN70, Lane 5: CnYpd1 + CnYpd1 ΔN70, Lane 6: 2 
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 Size exclusion chromatography with multi-angle light scattering analysis was 
performed on CnYpd1 protein fractions collected from anion exchange. The theoretical 
molecular weight for CnYpd1 was calculated to be ~27.6 kDa. The experimentally 
determined molecular weight obtained from SEC-MALS calculates was determined to 
be 27.1 ± 1.99 kDa. These results indicate that CnYpd1 functions in solution as a 
monomer. Experiment was performed in triplicate. 
 
 Taken together there is more evidence to support CnYpd1 functioning as a 
monomer in solution than a dimer, contrary to SEC results predicted molecular weight 
results. This observation is most likely due to the irregular shape of the protein 
Additional experiments such as analytical ultracentrifugation would need to be 




Figure 32. SEC-MALS of CnYpd1 
SEC-MALS was performed on CnYpd1 in a 20 mM Tris pH 8.0, 150 mM NaCl buffer. Red 
indicates light scattering signal and green indicates UV signal.  
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2.3.5 CnYpd1 exhibits an extended phosphorylated lifetime in comparison to 
other HPt proteins 
 
To investigate the stability of the phosphoryl group on CnYpd1, phospho-
stability experiments were performed, again using ScSln1-HKR1 as a phosphoryl 
donor. CnYpd1 was phosphorylated in the presence of ScSln1-HKR1 for 5 minutes, 
ScSln1-HKR1 was removed from solution and aliquots were taken over time of 
CnYpd1 (Figure 33). Significant protein degradation was observed after 42 hours.  In 
comparison to ScYpd1, which has a phosphorylated half-life of approximately 4 hours 
[39], CnYpd1 exhibited a significantly extended phosphorylated life-time.  
 
Experiments were performed on both protein with the affinity tag present, and 
with the affinity tag removed to ensure that the extended phospho-stability observed 
was not a result of the presence of the affinity tag. A comparable phospho-stability was 
observed, indicating that the affinity tag was not responsible for the extended phospho-
stability (Figure 34).  
 
 
Figure 33. Extended phosphorylated life-time of CnYpd1 
The histidine kinase and receiver domains from the heterologous donor ScSln1 (ScSln1-HKR1) were 
used as a phospho-donor for CnYpd1.  Phosphorylated ScSln1-HKR1 was removed from the reaction 
and aliquots of CnYpd1 were taken at specified time points. Three replicates were performed. 
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2.3.6 N-terminal region stabilizes phosphoryl group on CnYpd1 
 
According to sequence alignments of CnYpd1 with ScYpd1 and other Ypd1 
homologs (Figure 20), CnYpd1 contains an extended N-terminal. Because ScYpd1 
lacks the extended N-terminal region present in CnYpd1, it was hypothesized that it is 
this region which is responsible for the stabilization of the phosphoryl group on 
CnYpd1. CnYpd1 ΔN70 was chosen to repeat phospho-stability experiments. CnYpd1 
ΔN70 is most similar to ScYpd1 in that it is predominantly composed of only an HPt 
domain and subsequent deletion mutants (ΔN77, ΔN83, and ΔN100) were found to be 
insoluble (Table 6). Phospho~GST-ScSln1-HKR1 was used as a donor to 
phosphorylate CnYpd1 ΔN70 and removed from the reaction by gentle centrifugation, 
leaving only CnYpd1 ΔN70 present in the reaction.  Aliquots were removed at specific 
time points. The phosphorylated half-life of CnYpd1 ΔN70 was determined to be 3.4 ± 
0.63 hours (N=4) (Figure 35).  This half-life is significantly different than that of full 
 
Figure 34. Phosphoryl stability of CnYpd1 after affinity tag removal 
Affinity tag was removed from pure CnYpd1 protein with TEV protease. Bead bound GST-
ScSln1-HKR1 was used as a phospho-donor to phosphorylate CnYpd1.  GST-ScSln1-HKR1 was 
removed from the reaction once transfer from GST-ScSln1-HKR1 to CnYpd1 was complete and 
aliquots of CnYpd1 were taken at specific time points and quenched with stop buffer. 0 hour time 
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length protein, for which a half-life was not able to be determined. These data suggests 
a role for N-terminal region of CnYpd1 in stabilizing the phosphoryl group. 
 
2.3.7 CnYpd1 binds calcium ions in a 2:1 molar ratio 
 
An observation was made while performing size exclusion during protein 
purification that the addition of EDTA resulted in a slight but reproducible shift in the 
elution volume of CnYpd1 on a calibrated S200 column.  A shift from an elution 
volume of 14.7 in the absence of EDTA to 14.93 in the presence of EDTA was 
observed (Figure 36).   
 
Figure 35. CnYpd1 ΔN70 dephosphorylation 
CnYpd1 ΔN70 was incubated with phospho~GST-ScSln1-HKR1. GST-ScSln1-HKR1 was removed 
from the reaction. Aliquots were removed and mixed with stop buffer to quench the reaction. (A) 
All data points for phosphorylated half-life experiments for CnYpd1 ΔN70. (B) Representative 
phosphorimage that shows dephosphorylation of CnYpd1 ΔN70 over time. A phosphorylated half-
life of 3.4 ± 0.63 hours (N=4) was calculated.  
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 In order to test whether the elution volume shift was simply a result of column 
variability or due to the presence or absence of EDTA, an experiment involving the re-
introduction of metal ions to the protein sample was performed. In order to test whether 
this shift in elution volume was simply a result of column variability or due to the 
presence or absence of metal ions, an experiment involving the re-introduction of metal 
ions to the protein sample was performed. CnYpd1 protein was treated with 1 mM 
EDTA for 3 hours.  EDTA was removed by buffer exchange into buffer lacking EDTA.  
Metal ions were reintroduced to the protein by incubation with each metal ion for 3 
 
Figure 36.  CnYpd1 shows a shift in elution volume in the presence and 
absence of EDTA 
Chromatograms obtained from Superdex 200 column using AKTÄ Pure M1 system when CnYpd1 
was applied to the S200 column in the presence and absence of EDTA.  
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hours. SEC was then performed on each sample (Figure 37). 
 
 Re-introduction of metal ions after treatment of the protein samples with 1 mM 
EDTA resulted in a small shift in the elution volume of the protein from 14.1 to 13.8 at 
pH 8.  Several divalent metal ions were chosen (calcium, cobalt, manganese, and 
magnesium) based on literature searches. Magnesium is often required for proper 
phosphotransfer to occur in His-to-Asp systems, and other metal ions such as calcium 
have been previously shown to inhibit phosphotransfer [44]. There was no observable 
change in the elution volume of CnYpd1 based on which metal ion was present (Figure 
 
Figure 37. Re-introduction of metal ions to CnYpd1 causes a change in the 
elution volume during SEC 
Chromatograms obtained from Superdex 200 column using AKTÄ Pure M1 system. Protein sample 
was tested at pH 5 (a) and pH 8 (b) in the presence of EDTA. Fractions were pooled and split into 4 
equal parts. Metal ions were re-introduced into protein and incubated for ~3 hours.   Fractions were 
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37), indicating that any divalent metal ion present may be a possible substitution for the 
naturally occurring metal ion.  
 ICP-MS experiments were performed on 
CnYpd1, CnYpd1 ΔN50 and CnYpd1 ΔN70 to 
determine the type of metal present and molar 
ratio. Metal ion concentrations were determined 
for calcium, cobalt, copper, magnesium, nickel 
and zinc for wild-type CnYpd1. All metal ions 
with the exception of calcium in the full length protein were found in insignificant 
concentrations (Table 9). Subsequent ICP-MS experiments only determined the 
concentration of calcium present.
 
 















CnYpd1 FL 1812.51 3968.00 1.38 0.04 0.84 0.53 3.56 
CnYpd1 FL 1812.51 3230.00 1.77 0.03 0.87 0.63 4.31 
CnYpd1 
ΔN70 
2242.71 12.64 1.04 0.03 5.39 1.49 31.92 






--- --- --- --- --- 
CnYpd1 FL 36.25 83.83 --- --- --- --- --- 
CnYpd1 
ΔN70 
49.84 21.35 --- --- --- --- --- 
CnYpd1 Δ50 44.94 3.76 --- --- --- --- --- 






--- --- --- --- --- 
E58A 18.13 18.13 --- --- --- --- --- 
D60A-E67A 29.0 14.50 --- --- --- --- --- 
E48A-E54A 1.81 3.63 --- --- --- --- --- 
Buffer --- 3.99 --- --- --- --- --- 
 
 
Figure 38. CnYpd1 and 
CnYpd1 ΔN70 protein samples 
for ICP-MS 
Coomassie stained protein samples 
sent to OHSU for ICP-MS studies. 
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 Molar ratios of each metal ion per 
protein molecule were calculated (Table 
10). The ratio of calcium ions per CnYpd1 
full-length protein was determined to be 
2:1, whereas calcium was far below 
stoichiometric amounts for the CnYpd1 
ΔN70 and ΔN50 mutants (essentially a 0:1 
ratio). This suggests that the first 70 
residues of CnYpd1 of the extended N-
terminal region are responsible for metal ion binding.  
A comprehensive sequence alignment was performed on all stand-alone HPt 
proteins found in the NCBI data base. Of the 2000 sequences found for stand-alone HPt 
proteins, approximately 80 were found to contain an extended N-terminal extension.  
These proteins were realigned using only the non-HPt containing region using 
ClustalX2. Two regions of higher sequence homology were observed (Figure 39) [45] 
corresponding to highly acidic segments of the N-terminal region of CnYpd1, residues 
from approximately E48 to E67 . BLAST results obtained using this region of CnYpd1 
indicated that it was also homologous to proteins known to bind both calcium and zinc 
metal ions.   
Table 10. Calculated molar ratio of 
metal ions per protein based on ICP-
MS 
Protein Ca2+ 
CnYpd1 ΔN70 0.0 
CnYpd1 FL 2.19 
CnYpd1 FL 1.78 
Protein  
CnYpd1 FL 2.11 
CnYpd1 ΔN70 0.28 
CnYpd1 ΔN50 0.08 
Protein  
CnYpd1 E58A 0.92 
CnYpd1 D60A-E67A 0.23 
CnYpd1 E48A-E54A  2.05 
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 Three mutant CnYpd1 constructs were created, E58A, E48A-E54A, and D60A-
E67A, and subjected to ICP-MS analysis. Previous results indicated that wild-type 
CnYpd1 is able to bind calcium ions in a 2:1 molar ratio.  CnYpd1 E58A showed the 
presence of only one calcium ion per protein molecule, while the E48A-E54A mutant 
showed two calcium ions bound per protein molecule and the D60A-E67A mutant 
showed no calcium present (Table 10).  These results suggest that residue E58 and the 
region between D60 to E67 of the N-terminal domain are responsible for calcium ion 
binding.  
2.3.8 Calcium is not required for phosphorylation of CnYpd1 
 
To determine if the bound calcium ions are required for phosphorylation of 
CnYpd1,  metal ions were removed from the protein by addition of EDTA for 30 
minutes. EDTA was removed from the protein sample using a HiTrap Desalting column 
on an AKTA prime chromatography system. Untreated CnYpd1 was used as a control. 
Samples were subjected to a phosphotransfer assay. The phosphotransfer reaction was 
performed in the presence of both calcium (Figure 40A) and magnesium (Figure 40B) . 
Untreated CnYpd1 was used as a control. Samples was subjected to a phosphotrasnfer 
assay The phosphotransfer reaction was done in the presence of both calcium (Figure 
 
Figure 39. Highly homologous region of N-terminal sequence alignment. 
Frequency of residues found in highly homologous region of HPt proteins with N-terminal 
extensions.  Height of residue indicates higher frequency.  
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40A) and magnesium (Figure 40B). 
 Only slight differences were observed for phosphorylation of CnYpd1 in the 
presence of calcium versus magnesium, indicating that calcium is not required for 
phosphotransfer.  Furthermore, it was noted that degradation of the protein occurred for 
the EDTA-containing protein samples suggesting that calcium may be required for 
structural integrity. CnYpd1 E58A and CnYpd1 D60A-E67A were also subjected to 
phosphotransfer assay. Neither the E58A mutant nor the D60A-E67A double mutant 
showed any difference in the ability to accept a phosphoryl group from ScSln1-HKR1 
(Figure 40C). These results indicate that the calcium bound to CnYpd1 is not required 
for phosphorylation of CnYpd1, and likely serves other functions such as stabilizing the 
structure of the N-terminal region.  
 
 
      
Figure 40. Phosphorylation of CnYpd1, CnYpd1 E58A and CnYpd1 D60A-
E67A 
Phospho~ScSln1-HKR1 was used as a donor to CnYpd1 constructs and removed from the reaction 
after 2 minutes. (A) Autophosphorylation of bead-bound ScSln1-HKR1 was performed in the 
presence of 10 mM MgCl2. Bead-bound ScSln1-HKR1 was split into two fractions and each was 
washed by gentle pelleting of resin and addition of reaction buffer with either 10 mM MgCl2 or 
CaCl2. CnYpd1 was added to each ScSln1-HKR1 in the presence of  CaCl2 (A)  or  MgCl2 (B) 
containing tube, ScSln1-HKR1 was removed from the reaction after 1 minute and aliquots were 
taken of only CnYpd1 at 1, 5, and 15 minutes (lane designations indicate time points). (C) CnYpd1 
E58A and CnYpd1 D60A-E67A were phosphorylated using ScSln1-HKR1.  ScSln1-HKR1 was 
removed from the reaction after 1 minute and aliquots were taken Lane 1: WT CnYpd1, Lane 2: 
CnYpd1 E58A, lane 3: CnYpd1 D60A- E67A. 
A. C. B. 1         2         3
1         2         3 1         2         3 1         2         3 1         2         3
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2.3.9 Crystallization attempts for CnYpd1 
 
Extensive crystallography attempts were made using several CnYpd1 constructs.  
Attempts included variations in initial protein conditions, such as protein concentration, 
buffer components (salts, pH) and protein constructs. Most results from broad screens 
yielded spherulite-like crystals that could not be further optimized (see Appendix B: 
Crystallography attempts for CnYpd1). DLS was performed on CnYpd1 protein 
sample prepared in PBS. Results from DLS indicated that the most suitable buffer for 
mono-dispersity was 50 mM Tris pH 8.0 and 200 mM NaCl (Figure 41).  
Further DLS studies were completed in protein prepared in this 50 mM Tris pH 8.0 and 
200 mM NaCl buffer using additive screens (Figure 42 and Figure 43).   
 
Figure 41. Analysis of oligomeric distribution of CnYpd1 by DLS 








Crystallography attempts were repeated based on the best results found from 
DLS experiments. These attempts also yielded spherulite-like crystals. Other attempts 
using additive screens produced long fiber like crystals that did not diffract well for data 
collection.  
 
Figure 42. Analysis of oligomeric distribution of CnYpd1 by DLS 
1.5 mg/mL CnYpd1 was prepared in 50 mM Tris pH 8.0 and 200 mM NaCl. A final concentration 
of 0.06% Tween 20 was added to the protein. 
 
 
Figure 43.  Analysis of oligomeric distribution of CnYpd1 by DLS 
1.5 mg/mL CnYpd1 was prepared in 50 mM Tris pH 8.0 and 200 mM NaCl. A final concentration 
of 20 mM n-Octyl-β-D-glucoside (OG) was added to the protein. 
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2.3.10 Discussion 
Very few HPt proteins with N-terminal domains are found in nature.  A 
phylogenetic tree of organisms which encode stand-alone HPt proteins with extended 
N-terminal domains was created using phyloT and visualized using iTOL [46] (Figure 
44).   Analysis of the phylogenetic tree revealed that the vast majority of organisms 
which contain these proteins have either been shown to be pathogenic to humans or 
plants, or to live in highly diverse environments, such as locations of extreme cold. The 
majority of the species with HPt proteins with an extended N-terminal region belong to 
Ascomycota phylum, but several are also found in the Basidiomycota phylum.  
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Although the model yeast S. cerevisiae encodes a single HHK, a single HPt, and 
2 RR proteins compartmentalized to the cytoplasm and nucleus, filamentous and 
pathogenic Ascomycetes and Basidiomycetes fungi have been observed to have 
 
Figure 44. Phylogenetic tree of HPt proteins with extended N-terminal region 
Phylogenetic tree created based on sequence alignment of stand-alone HPt proteins with extended N-
terminal regions.  An ‘extended’ N-terminal domain was defined as any encoded sequence extended 
greater than at least 20 residues from the start site of S. cerevisiae Ypd1. Escherichia coli was used 
as an out group and is designated in grey.  Purple represents the Fungi kingdom, orange the phylum 
Zygomycota, green Basidiomycota, and blue Ascomycota. Pathogenic organisms are denoted by a * 
and extremophiles by a +. 
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expanded families of HHK and RR proteins. The number of HHKs encoded by an 
organism is highly variable: the plant pathogen Bipolaris maydis encodes 21 HHK 
proteins; human pathogens C. albicans encodes 3 HHK proteins, Trichosporon asahii 
has 8 HHK proteins and C. neoformans has 7 HHKs [16]. Although the number of 
HHK proteins encoded has been greatly expanded, the majority of fungal organisms 
still only encode 2-5 RR, proteins and a single HPt protein [13]. This makes the HPt 
protein solely responsible for shuttling the phosphoryl group from numerous HHK 
proteins to the cognate RR protein depending on the stimuli sensed by the HHK. 
Addition of an N-terminal extension to the HPt protein may allow for more specific 
interaction between the HHK and the HPt or the HPt and the RR.  For example, the 
extended N-terminal region of the Ypd1 homolog Mpr1 from S. pombe has been shown 
to influence phosphotransfer effiency between its cognate HHK binding partner Mak2 
by contributing to the protein-protein interactions [47]. Thus, diverse functions, such as 
metal ion binding or stabilization of the phosphoryl group, may allow for specific 
functions of the N-terminal region and alter the way that the HPt interacts with its 
binding partners.  
 In summary, we show that the C-terminal region of the Ypd1 homolog from C. 
neoformans indeed functions as an HPt domain. It is able to accept and transfer 
phosphoryl groups to heterologous donors/acceptors, with residue H138 being the site 
of phosphorylation. Our data indicates that the N-terminal region of CnYpd1 confers 
the following structural and functional properties to CnYpd1 that differentiates this 
protein from other HPt domains that lack the N-terminal region.  The N-terminal region 
(i) is essential for protein solubility, (ii) stabilizes the phosphorylated conformation, and 
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(iii) binds 2 calcium ions per protein monomer. A question remains with regard to the 
primary function of metal ion binding. We find that Ca2+-binding is not required for 
phosphorylation of CnYpd1 and is more likely to contribute to the structural integrity of 
the N-terminal domain alone and/or full-length protein or perhaps is involved in a yet 
undetermined sensory function of N-terminal domain.   
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Appendix A: Table of West Lab plasmids, cell strains, and primers 
Table 11. OU Construct Summary 



























































































































































































































































































































































































































































































Table 12. Oligo names, OU numbers, and Sequences 









pTrcHis Forward 774 5’-GAGGTATATATTAATGTATCG-3’ 



























































E54A Forward 1073 
5’-GCAGCGGCCGCGGCGGCGGCTGCGGCCGAAGCG-3’ 
CnYpd-E48A-
E54A Reverse 1074 
5’-CGCCGCCGCGGCCGCTGCACTCTGCTCCCGACTTGACTC-3’ 
 108   
 
CnYpd1-D60A-
E67A Forward 1075 
5’-GCAGCGGCCGCGGCGGCGGCAGCACCAGAGACCGGCGATGAAATC-3’ 
CnYpd1-D60A-
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Appendix B: Crystallography attempts for CnYpd1   








12/7/2012 CnYpd1tag 10 
10mM Bis-tris pH 








12/17/2012 CnYpd1tag 3 
10mM Bis-tris pH 








2/7/13 CnYpd1tag 20 
10mM Bis-tris pH 







2/8/15 CnYpd1tag 20 
10mM Bis-tris pH 





4/5/13 CnYpd1tag 18 
20 mM Tris pH 7.0, 




(Table 14) +/- 
Reducing agent 
 ScYpd1 
Optimization Screen  
(Table 14) + Silver 
Bullet 
6/14/13 CnYpd1tag 10 
50 mM Tris pH 7.0, 






7/18/13 CnYpd1tag 10 
50 mM Tris pH 7.0, 
50 mM KCl 
------- 1:1 
 MCSGII B1 
Optimization Screen 
1 (Table 15) 
 MCSGII B1 
Optimization Screen 
2 (Table 16) 
7/18/13 CnYpd1tag 10 
50 mM Tris pH 7.0, 
50 mM KCl 
------- 1:1 
 MCSG III E5 
Optimization Screen 
(Table 17)  
 
 







20 mM Tris pH 7, 














20 mM Tris pH 7, 











20 mM Tris pH 7.5, 


























27 20 mM Tris pH 7.5 ------- 1:1 
Octanetriol Opt. 1 
(Table 18) 
 
Higher concentration of protein produced larger more needle-like crystals than the hair-like crystals 






13.5 20 mM Tris pH 7.5 ------- 1:1 
Octanetriol Opt. 2 
(Table 20) 




Needle like crystals observed with the additive 1,2,3-octanetriol isomer H, however diffraction 
pattern was inconclusive. 
 







9 20 mM Tris pH 7.5 ------- 1:1 












 113   
 
10/18/13 CnYpd1tagless 10 
20 mM Bis-tris pH 









Spherulite crystals were observed from the MCSG I Screen. Small crystals were also seen from the 
CSHT Screen. Optimization screens were created around the CSHT D3 condition (Table 22). 
Further optimization did not reproduce crystals. 
 
 
10/30/13 CnYpd1tagless 10 
20 mM Bis-tris pH 































Small seed-like crystals were seen for several conditions containing lithium salts. Optimization 





7 PBS ------- 1:1 
 CSHT H5 Opt. 
(Table 22)  
 Index G11 Opt. 
(Error! Reference 
ource not found.)  
 JCSG D7 Opt. 
(Table 23)  
 MCSG 1 C5 Opt. 
(Table 24)  
 





















9/23/15 CnYpd1 ΔN60 10 
20 mM Tris pH 8.0, 
150 mM NaCl, 




4/26/16 CnYpd1 10 
20 mM Tris pH 8.0, 
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Table 14. ScYpd1 Optimization Screen 























38% PEG 4000 
0.1 M Ammonium 
Acetate 























38% PEG 4000 
0.2 M Ammonium 
Acetate 






















38% PEG 4000 
0.3 M Ammonium 
Acetate 























38% PEG 4000 
0.4 M Ammonium 
Acetate 
 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 17. MCSG III E5 Optimization Screen 1 
0.1 M 
Sodium 
Citrate pH 5  















































Citrate pH 5  















































Citrate pH 5  















































Citrate pH 5  














































Table 18. CnYpd1-H138Q Optimization 1 + 0.5 M 1,2,3-octanetriol isomer H 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 





0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 





0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 






0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 












0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 







0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 







0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 







0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 




0.5 M Sodium 





Table 20. Octanetriol Optimization 2 

































































































































































































Table 21. CSHT D3 Optimization 
      Seed 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
10-6 
0.1 M HEPES 




1.8% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




2.0% PEG 400 
0.1 M HEPES 




2.2% PEG 400 
0.1 M HEPES 




2.4% PEG 400 
0.1 M HEPES 




2.6% PEG 400 
10-6 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
10-3 
0.1 M HEPES 




1.8% PEG 400 
0.1 M HEPES 




1.6% PEG 400 
0.1 M HEPES 




2.0% PEG 400 
0.1 M HEPES 




2.2% PEG 400 
0.1 M HEPES 




2.4% PEG 400 
0.1 M HEPES 




2.6% PEG 400 
10-3 
 
Table 22. CSHT H5 Optimization 
0.1 M Tris pH 
8.5 
0.6 M Lithium 
Sulfate 
0.01 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
0.8 M Lithium 
Sulfate 
0.02 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.0 M Lithium 
Sulfate 
0.03 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.2 M Lithium 
Sulfate 
0.04 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.4 M Lithium 
Sulfate 
0.05 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.6 M Lithium 
Sulfate 
0.06 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
0.6 M Lithium 
Sulfate 
0.01 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
0.8 M Lithium 
Sulfate 
0.02 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.0 M Lithium 
Sulfate 
0.03 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.2 M Lithium 
Sulfate 
0.04 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.4 M Lithium 
Sulfate 
0.05 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.6 M Lithium 
Sulfate 
0.06 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
0.6 M Lithium 
Sulfate 
0.01 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
0.8 M Lithium 
Sulfate 
0.02 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.0 M Lithium 
Sulfate 
0.03 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.2 M Lithium 
Sulfate 
0.04 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.4 M Lithium 
Sulfate 
0.05 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.6 M Lithium 
Sulfate 
0.06 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
0.6 M Lithium 
Sulfate 
0.01 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
0.8 M Lithium 
Sulfate 
0.02 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.0 M Lithium 
Sulfate 
0.03 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.2 M Lithium 
Sulfate 
0.04 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.4 M Lithium 
Sulfate 
0.05 M Nickel 
Chloride 
0.1 M Tris pH 
8.5 
1.6 M Lithium 
Sulfate 
0.06 M Nickel 
Chloride 
 










Table 23. JCSG D7 Optimization 
0.1 M Tris pH 
8.5 
0.1 M Lithium 
Sulfate 
32% PEG 400 
0.1 M Tris pH 
8.5 
0.1 M Lithium 
Sulfate 
34% PEG 400 
0.1 M Tris pH 
8.5 
0.1 M Lithium 
Sulfate 
36% PEG 400 
0.1 M Tris pH 
8.5 
0.1 M Lithium 
Sulfate 
38% PEG 400 
0.1 M Tris pH 
8.5 
0.1 M Lithium 
Sulfate 
40% PEG 400 
0.1 M Tris pH 
8.5 
0.1 M Lithium 
Sulfate 
42% PEG 400 
0.1 M Tris pH 
8.5 
0.05 M Lithium 
Sulfate 
32% PEG 400 
0.1 M Tris pH 
8.5 
0.05 M Lithium 
Sulfate 
34% PEG 400 
0.1 M Tris pH 
8.5 
0.05 M Lithium 
Sulfate 
36% PEG 400 
0.1 M Tris pH 
8.5 
0.05 M Lithium 
Sulfate 
38% PEG 400 
0.1 M Tris pH 
8.5 
0.05 M Lithium 
Sulfate 
40% PEG 400 
0.1 M Tris pH 
8.5 
0.05 M Lithium 
Sulfate 
42% PEG 400 
0.1 M Tris pH 
8.5 
0.2 M Lithium 
Sulfate 
32% PEG 400 
0.1 M Tris pH 
8.5 
0.2 M Lithium 
Sulfate 
34% PEG 400 
0.1 M Tris pH 
8.5 
0.2 M Lithium 
Sulfate 
36% PEG 400 
0.1 M Tris pH 
8.5 
0.2 M Lithium 
Sulfate 
38% PEG 400 
0.1 M Tris pH 
8.5 
0.2 M Lithium 
Sulfate 
40% PEG 400 
0.1 M Tris pH 
8.5 
0.2 M Lithium 
Sulfate 
42% PEG 400 
0.1 M Tris pH 
8.5 
0.3 M Lithium 
Sulfate 
32% PEG 400 
0.1 M Tris pH 
8.5 
0.3 M Lithium 
Sulfate 
34% PEG 400 
0.1 M Tris pH 
8.5 
0.3 M Lithium 
Sulfate 
36% PEG 400 
0.1 M Tris pH 
8.5 
0.3 M Lithium 
Sulfate 
38% PEG 400 
0.1 M Tris pH 
8.5 
0.3 M Lithium 
Sulfate 
40% PEG 400 
0.1 M Tris pH 
8.5 
0.3 M Lithium 
Sulfate 
42% PEG 400 
 
Table 24. MCSG I C5 Optimization 





































































































Table 25. MCSG I C5 Optimization 
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Appendix C: Table of Abbreviations 
5-IAF: 5-iodoacetamidofluorescein 
ATP: Adenosine triphosphate 
CA: Catalytic and ATP binding domain 
CBD: Chitin binding domain 
Cn: Cryptococcus neoformans 
CoV: Coefficient of variance 
CV: Column volume 
DHp: Dimerization and Histidine phosphotransfer 
EK: Enterokinase 
GBAP: gelatinase biosynthesis-activating pheromone 
GST: Glutathione S-transferase 
HHK: Hybrid histidine kinase 
His-to-Asp: Histidine-to-Aspartate 
HK: Histidine kinase 
HOG: High Osmolarity Glycerol  
HPt: Histidine-phosphotransfer protein 
ICP-MS: Inductively coupled plasma mass spec 
IPTG - Isopropyl β-D-1-thiogalactopyranoside  
LB: Luria Broth 
MAPK: Mitogen Activated Protein Kinase 
Ni-NTA resin: Nickel Nitrilotriacetic acid resin 
OMRF: Oklahoma Medical Research Foundation 
P2CS: Prokaryotic 2-Component Systems 
PCR: Polymerase chain reaction 
PDB: Protein Data bank 
PPC: Protein Production Core  
Rec: Receiver domain 
RR: Response regulator 
R1: Receiver domain of Sln1 
R2: Receiver domain of Ssk1 
R3: Receiver domain of Skn7 
Sc: Saccharomyces cerevisiae 
SEC: Size exclusion chromatography 
SEC-MALS: Size exclusion chromatography with multi-angle light scattering  
SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TEV: Tobacco etch virus protease 
WT: Wild type 
 
